{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:56:08Z","timestamp":1792176968674,"version":"4.4.0"},"reference-count":254,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-07884-x","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T13:02:12Z","timestamp":1772629332000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The value of targeting ketone body metabolism in inflammatory and autoimmune diseases"],"prefix":"10.1186","volume":"24","author":[{"given":"Yanmei","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9588-8326","authenticated-orcid":false,"given":"Tong","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"issue":"6","key":"7884_CR1","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/(sici)1520-7560(199911\/12)15:6<412:aid-dmrr72>3.0.co;2-8","volume":"15","author":"L Laffel","year":"1999","unstructured":"Laffel L. Ketone bodies: a Review of Physiology, pathophysiology and application of monitoring to Diabetes. Diabetes Metab Res Rev. 1999;15(6):412\u201326. https:\/\/doi.org\/10.1002\/(sici)1520-7560(199911\/12)15:6%26lt;412:aid-dmrr72%26gt;3.0.co;2-8.","journal-title":"Diabetes Metab Res Rev"},{"issue":"15","key":"7884_CR2","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1016\/j.jacc.2018.06.040","volume":"72","author":"TA Zelniker","year":"2018","unstructured":"Zelniker TA, Braunwald E. Cardiac and renal effects of Sodium-Glucose Co-Transporter 2 inhibitors in Diabetes: jacc state-of-the-art Review. J Am Coll Cardiol. 2018;72(15):1845\u201355. Epub 20180731. doi: https:\/\/doi.org\/10.1016\/j.jacc.2018.06.040.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"7884_CR3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.tem.2023.10.002","volume":"35","author":"PMM Ruppert","year":"2024","unstructured":"Ruppert PMM, Kersten S. Mechanisms of hepatic fatty acid oxidation and ketogenesis during Fasting. Trends Endocrinol Metab. 2024;35(2):107\u201324. Epub 20231106. doi: https:\/\/doi.org\/10.1016\/j.tem.2023.10.002.","journal-title":"Trends Endocrinol Metab"},{"key":"7884_CR4","doi-asserted-by":"publisher","unstructured":"Mishra PK. Why the Diabetic Heart is energy inefficient: a ketogenesis and ketolysis perspective. Am J Physiol Heart Circ Physiol. 2021;321(4):H751\u20135. Epub 20210917. doi: https:\/\/doi.org\/10.1152\/ajpheart.00260.2021.","DOI":"10.1152\/ajpheart.00260.2021"},{"key":"7884_CR5","doi-asserted-by":"publisher","first-page":"583611","DOI":"10.3389\/fnins.2020.583611","volume":"14","author":"J Lin","year":"2020","unstructured":"Lin J, Huang Z, Liu J, Huang Z, Liu Y, Liu Q, et al. Neuroprotective Effect of ketone metabolism on Inhibiting inflammatory Response by Regulating Macrophage polarization after Acute cervical spinal cord injury in Rats. Front Neurosci. 2020;14:583611. Epub 20201023. doi: https:\/\/doi.org\/10.3389\/fnins.2020.583611.","journal-title":"Front Neurosci"},{"key":"7884_CR6","doi-asserted-by":"publisher","unstructured":"Jang J, Kim SR, Lee JE, Lee S, Son HJ, Choe W, et al. Molecular mechanisms of Neuroprotection by ketone bodies and Ketogenic Diet in cerebral ischemia and neurodegenerative diseases. Int J Mol Sci. 2023;25(1). Epub 20231221. doi: https:\/\/doi.org\/10.3390\/ijms25010124.","DOI":"10.3390\/ijms25010124"},{"issue":"1","key":"7884_CR7","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s42003-024-05860-z","volume":"7","author":"J Di Lucente","year":"2024","unstructured":"Di Lucente J, Persico G, Zhou Z, Jin LW, Ramsey JJ, Rutkowsky JM, et al. Ketogenic Diet and Bhb Rescue the Fall of Long-term potentiation in an Alzheimer\u2019s mouse model and stimulates synaptic Plasticity pathway enzymes. Commun Biol. 2024;7(1):195. Epub 20240216. doi: https:\/\/doi.org\/10.1038\/s42003-024-05860-z.","journal-title":"Commun Biol"},{"key":"7884_CR8","doi-asserted-by":"publisher","first-page":"591177","DOI":"10.3389\/fnins.2020.591177","volume":"14","author":"E Hu","year":"2020","unstructured":"Hu E, Du H, Shang S, Zhang Y, Lu X. Beta-Hydroxybutyrate Enhances bdnf expression by increasing H3k4me3 and decreasing H2ak119ub in hippocampal Neurons. Front Neurosci. 2020;14:591177. Epub 20201028. doi: https:\/\/doi.org\/10.3389\/fnins.2020.591177.","journal-title":"Front Neurosci"},{"key":"7884_CR9","doi-asserted-by":"publisher","unstructured":"Pawlowska M, Kruszka J, Porzych M, Garbarek J, Nuszkiewicz J. Ketogenic metabolism in neurodegenerative diseases: mechanisms of Action and therapeutic potential. Metabolites. 2025;15(8). Epub 20250731. doi: https:\/\/doi.org\/10.3390\/metabo15080508.","DOI":"10.3390\/metabo15080508"},{"issue":"7","key":"7884_CR10","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1161\/CIRCRESAHA.123.321872","volume":"132","author":"TR Matsuura","year":"2023","unstructured":"Matsuura TR, Puchalska P, Crawford PA, Kelly DP. Ketones and the Heart: metabolic principles and therapeutic Implications. Circ Res. 2023;132(7):882\u201398. Epub 20230330. doi: https:\/\/doi.org\/10.1161\/CIRCRESAHA.123.321872.","journal-title":"Circ Res"},{"key":"7884_CR11","doi-asserted-by":"publisher","first-page":"1463381","DOI":"10.3389\/fphar.2024.1463381","volume":"15","author":"K Liu","year":"2024","unstructured":"Liu K, Yang Y, Yang JH. Underlying mechanisms of Ketotherapy in Heart failure: current evidence for clinical Implementations. Front Pharmacol. 2024;15:1463381. Epub 20241024. doi: https:\/\/doi.org\/10.3389\/fphar.2024.1463381.","journal-title":"Front Pharmacol"},{"issue":"12","key":"7884_CR12","doi-asserted-by":"publisher","first-page":"584","DOI":"10.4239\/wjd.v11.i12.584","volume":"11","author":"S Nasser","year":"2020","unstructured":"Nasser S, Vialichka V, Biesiekierska M, Balcerczyk A, Pirola L. Effects of Ketogenic Diet and ketone bodies on the Cardiovascular System: concentration matters. World J Diabetes. 2020;11(12):584\u201395. https:\/\/doi.org\/10.4239\/wjd.v11.i12.584.","journal-title":"World J Diabetes"},{"key":"7884_CR13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1146\/annurev-nutr-111120-111518","volume":"41","author":"P Puchalska","year":"2021","unstructured":"Puchalska P, Crawford PA. Metabolic and signaling roles of ketone bodies in Health and Disease. Annu Rev Nutr. 2021;41:49\u201377. https:\/\/doi.org\/10.1146\/annurev-nutr-111120-111518.","journal-title":"Annu Rev Nutr"},{"issue":"2","key":"7884_CR14","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.cmet.2016.12.022","volume":"25","author":"P Puchalska","year":"2017","unstructured":"Puchalska P, Crawford PA. Multi-dimensional roles of ketone bodies in Fuel metabolism, signaling, and Therapeutics. Cell Metab. 2017;25(2):262\u201384. https:\/\/doi.org\/10.1016\/j.cmet.2016.12.022.","journal-title":"Cell Metab"},{"key":"7884_CR15","doi-asserted-by":"publisher","first-page":"101395","DOI":"10.1016\/j.redox.2019.101395","volume":"29","author":"P Rojas-Morales","year":"2020","unstructured":"Rojas-Morales P, Pedraza-Chaverri J, Bodies TEK. Stress Response, and Redox homeostasis. Redox Biol. 2020;29:101395. Epub 20191128. doi: https:\/\/doi.org\/10.1016\/j.redox.2019.101395.","journal-title":"Redox Biol"},{"key":"7884_CR16","doi-asserted-by":"publisher","first-page":"109101","DOI":"10.1016\/j.intimp.2022.109101","volume":"111","author":"S Luo","year":"2022","unstructured":"Luo S, Yang M, Han Y, Zhao H, Jiang N, Li L, et al. Beta-Hydroxybutyrate against cisplatin-Induced Acute Kidney injury via Inhibiting Nlrp3 inflammasome and oxidative stress. Int Immunopharmacol. 2022;111:109101. Epub 20220805. doi: https:\/\/doi.org\/10.1016\/j.intimp.2022.109101.","journal-title":"Int Immunopharmacol"},{"key":"7884_CR17","doi-asserted-by":"publisher","unstructured":"Liu K, Yang Q, Lang Y, Zou Y, Yuan J, Yang J, et al. Ketogenic Diet, Serum ketone bodies and risk of end-Stage renal Disease in Patients with Diabetic Kidney Disease: a Multi-cohort Study. J Diabetes. 2025;17(8):e70140. https:\/\/doi.org\/10.1111\/1753-0407.70140.","DOI":"10.1111\/1753-0407.70140"},{"issue":"13","key":"7884_CR18","doi-asserted-by":"publisher","first-page":"111437","DOI":"10.1016\/j.celrep.2022.111437","volume":"40","author":"CL Thio","year":"2022","unstructured":"Thio CL, Lai AC, Ting YT, Chi PY, Chang YJ. The ketone body Beta-Hydroxybutyrate Mitigates Ilc2-driven Airway inflammation by Regulating mast Cell function. Cell Rep. 2022;40(13):111437. https:\/\/doi.org\/10.1016\/j.celrep.2022.111437.","journal-title":"Cell Rep"},{"issue":"10","key":"7884_CR19","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1016\/j.cmet.2023.09.001","volume":"35","author":"KL Tomlinson","year":"2023","unstructured":"Tomlinson KL, Chen YT, Junker A, Urso A, Wong Fok Lung T, Ahn D, et al. Ketogenesis promotes tolerance to Pseudomonas Aeruginosa Pulmonary infection. Cell Metab. 2023;35(10):1767\u201381 e6. https:\/\/doi.org\/10.1016\/j.cmet.2023.09.001.","journal-title":"Cell Metab"},{"key":"7884_CR20","doi-asserted-by":"publisher","unstructured":"Zhou J, He M, Pu D, Yang T, Cheng Y, Wang R, et al. The ketone body Beta-Hydroxybutyrate Mitigates the ferroptosis of alveolar epithelial cells type Ii in bleomycin-Induced Pulmonary Fibrosis. Faseb J. 2025;39(15):e70920. https:\/\/doi.org\/10.1096\/fj.202501665R.","DOI":"10.1096\/fj.202501665R"},{"key":"7884_CR21","doi-asserted-by":"publisher","unstructured":"Grabacka M, Pierzchalska M, Dean M, Reiss K. Regulation of ketone body metabolism and the role of Pparalpha. Int J Mol Sci. 2016;17(12). Epub 20161213. doi: https:\/\/doi.org\/10.3390\/ijms17122093.","DOI":"10.3390\/ijms17122093"},{"key":"7884_CR22","doi-asserted-by":"publisher","unstructured":"Longo R, Peri C, Cricri D, Coppi L, Caruso D, Mitro N, et al. Ketogenic Diet: a New light shining on Old but gold Biochemistry. Nutrients. 2019;11(10). Epub 20191017. doi: https:\/\/doi.org\/10.3390\/nu11102497.","DOI":"10.3390\/nu11102497"},{"issue":"4","key":"7884_CR23","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.bbrc.2016.05.097","volume":"475","author":"M Nagao","year":"2016","unstructured":"Nagao M, Toh R, Irino Y, Mori T, Nakajima H, Hara T, et al. Beta-Hydroxybutyrate elevation as a compensatory Response against oxidative stress in Cardiomyocytes. Biochem Biophys Res Commun. 2016;475(4):322\u201328. Epub 20160520. doi: https:\/\/doi.org\/10.1016\/j.bbrc.2016.05.097.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"7884_CR24","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s42255-022-00528-6","volume":"4","author":"B Silva","year":"2022","unstructured":"Silva B, Mantha OL, Schor J, Pascual A, Placais PY, Pavlowsky A, et al. Glia Fuel Neurons with locally synthesized ketone bodies to sustain Memory under starvation. Nat Metab. 2022;4(2):213\u201324. Epub 20220217. doi: https:\/\/doi.org\/10.1038\/s42255-022-00528-6.","journal-title":"Nat Metab"},{"key":"7884_CR25","unstructured":"Dhillon KK, Gupta S Biochemistry, Ketogenesis. Statpearls. Treasure Island (FL)(2025."},{"key":"7884_CR26","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/9780470720691.ch7","volume":"87","author":"DW Foster","year":"1982","unstructured":"Foster DW, McGarry JD. The regulation of Ketogenesis. Ciba Found Symp. 1982;87:120\u201331. https:\/\/doi.org\/10.1002\/9780470720691.ch7.","journal-title":"Ciba Found Symp"},{"key":"7884_CR27","doi-asserted-by":"publisher","unstructured":"Hwang CY, Choe W, Yoon KS, Ha J, Kim SS, Yeo EJ, et al. Molecular mechanisms for ketone body metabolism, signaling functions, and therapeutic potential in Cancer. Nutrients. 2022;14(22). Epub 20221121. doi: https:\/\/doi.org\/10.3390\/nu14224932.","DOI":"10.3390\/nu14224932"},{"issue":"3","key":"7884_CR28","doi-asserted-by":"publisher","first-page":"103005","DOI":"10.1016\/j.jbc.2023.103005","volume":"299","author":"EL Goldberg","year":"2023","unstructured":"Goldberg EL, Letian A, Dlugos T, Leveau C, Dixit VD. Innate immune Cell-intrinsic ketogenesis is dispensable for organismal metabolism and Age-Related inflammation. J Biol Chem. 2023;299(3):103005. Epub 20230210. doi: https:\/\/doi.org\/10.1016\/j.jbc.2023.103005.","journal-title":"J Biol Chem"},{"issue":"Pt 2","key":"7884_CR29","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1113\/jphysiol.2007.138594","volume":"583","author":"K Pierre","year":"2007","unstructured":"Pierre K, Parent A, Jayet PY, Halestrap AP, Scherrer U, Pellerin L. Enhanced expression of three monocarboxylate Transporter isoforms in the Brain of Obese Mice. J Physiol. 2007;583(Pt 2):469\u201386. Epub 20070628. doi: https:\/\/doi.org\/10.1113\/jphysiol.2007.138594.","journal-title":"J Physiol"},{"issue":"3","key":"7884_CR30","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.plefa.2003.11.001","volume":"70","author":"T Fukao","year":"2004","unstructured":"Fukao T, Lopaschuk GD, Mitchell GA. Pathways and Control of ketone body metabolism: on the fringe of Lipid Biochemistry. Prostaglandins Leukot Essent Fat Acids. 2004;70(3):243\u201351. https:\/\/doi.org\/10.1016\/j.plefa.2003.11.001.","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"key":"7884_CR31","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.lfs.2017.07.003","volume":"183","author":"S Zhang","year":"2017","unstructured":"Zhang S, Xie C. The role of Oxct1 in the Pathogenesis of Cancer as a rate-limiting enzyme of ketone body metabolism. Life Sci. 2017;183:110\u201315. Epub 20170704. doi: https:\/\/doi.org\/10.1016\/j.lfs.2017.07.003.","journal-title":"Life Sci"},{"key":"7884_CR32","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-nutr-071816-064916","volume":"37","author":"JC Newman","year":"2017","unstructured":"Newman JC, Verdin E. Beta-Hydroxybutyrate: a signaling Metabolite. Annu Rev Nutr. 2017;37:51\u201376. https:\/\/doi.org\/10.1146\/annurev-nutr-071816-064916.","journal-title":"Annu Rev Nutr"},{"key":"7884_CR33","doi-asserted-by":"publisher","unstructured":"Xu R, He X, Xu J, Yu G, Wu Y. Immunometabolism: signaling pathways, homeostasis, and therapeutic targets. MedComm (2020). 2024;5(11):e789. Epub 20241103. doi: https:\/\/doi.org\/10.1002\/mco2.789.","DOI":"10.1002\/mco2.789"},{"issue":"4","key":"7884_CR34","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/s41422-020-0291-z","volume":"30","author":"EM Palsson-McDermott","year":"2020","unstructured":"Palsson-McDermott EM, O\u2019Neill LAJ. Targeting immunometabolism as an anti-inflammatory strategy. Cell Res. 2020;30(4):300\u201314. Epub 20200304. doi: https:\/\/doi.org\/10.1038\/s41422-020-0291-z.","journal-title":"Cell Res"},{"key":"7884_CR35","doi-asserted-by":"publisher","first-page":"805881","DOI":"10.3389\/fimmu.2022.805881","volume":"13","author":"J Qi","year":"2022","unstructured":"Qi J, Gan L, Fang J, Zhang J, Yu X, Guo H, et al. Beta-Hydroxybutyrate: a dual function Molecular and immunological barrier function Regulator. Front Immunol. 2022;13:805881. Epub 20220616. doi: https:\/\/doi.org\/10.3389\/fimmu.2022.805881.","journal-title":"Front Immunol"},{"key":"7884_CR36","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev.immunol.20.083001.084359","volume":"20","author":"CA Janeway Jr","year":"2002","unstructured":"Janeway CA Jr, Medzhitov R. Innate immune recognition. Annu Rev Immunol. 2002;20:197\u2013216. Epub 20011004. doi: https:\/\/doi.org\/10.1146\/annurev.immunol.20.083001.084359.","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"7884_CR37","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/ni.3123","volume":"16","author":"A Iwasaki","year":"2015","unstructured":"Iwasaki A, Medzhitov R. Control of Adaptive Immunity by the innate immune System. Nat Immunol. 2015;16(4):343\u201353. https:\/\/doi.org\/10.1038\/ni.3123.","journal-title":"Nat Immunol"},{"issue":"7329","key":"7884_CR38","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature09663","volume":"469","author":"R Zhou","year":"2011","unstructured":"Zhou R, Yazdi AS, Menu P, Tschopp J. A role for mitochondria in Nlrp3 inflammasome activation. Nature. 2011;469(7329):221\u201325. Epub 20101201. doi: https:\/\/doi.org\/10.1038\/nature09663.","journal-title":"Nature"},{"issue":"2","key":"7884_CR39","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/cmi.2015.95","volume":"13","author":"EK Jo","year":"2016","unstructured":"Jo EK, Kim JK, Shin DM, Sasakawa C. Molecular mechanisms Regulating Nlrp3 inflammasome activation. Cell Mol Immunol. 2016;13(2):148\u201359. Epub 20151109. doi: https:\/\/doi.org\/10.1038\/cmi.2015.95.","journal-title":"Cell Mol Immunol"},{"issue":"4","key":"7884_CR40","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/jcpe.13258","volume":"47","author":"J Zhang","year":"2020","unstructured":"Zhang J, Liu X, Wan C, Liu Y, Wang Y, Meng C, et al. Nlrp3 Inflammasome Mediates M1 Macrophage polarization and il-1beta production in inflammatory root resorption. J Clin Periodontol. 2020;47(4):451\u201360. Epub 20200207. doi: https:\/\/doi.org\/10.1111\/jcpe.13258.","journal-title":"J Clin Periodontol"},{"key":"7884_CR41","doi-asserted-by":"publisher","unstructured":"Seoane PI, Lee B, Hoyle C, Yu S, Lopez-Castejon G, Lowe M, et al. The Nlrp3-inflammasome as a sensor of organelle dysfunction. J Cell Biol. 2020;219(12). https:\/\/doi.org\/10.1083\/jcb.202006194.","DOI":"10.1083\/jcb.202006194"},{"issue":"3","key":"7884_CR42","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nm.3804","volume":"21","author":"YH Youm","year":"2015","unstructured":"Youm YH, Nguyen KY, Grant RW, Goldberg EL, Bodogai M, Kim D, et al. The ketone Metabolite Beta-Hydroxybutyrate blocks Nlrp3 Inflammasome-mediated inflammatory Disease. Nat Med. 2015;21(3):263\u201369. Epub 20150216. doi: https:\/\/doi.org\/10.1038\/nm.3804.","journal-title":"Nat Med"},{"issue":"9","key":"7884_CR43","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1016\/j.celrep.2017.02.004","volume":"18","author":"EL Goldberg","year":"2017","unstructured":"Goldberg EL, Asher JL, Molony RD, Shaw AC, Zeiss CJ, Wang C, et al. Beta-Hydroxybutyrate deactivates neutrophil Nlrp3 inflammasome to relieve gout flares. Cell Rep. 2017;18(9):2077\u201387. https:\/\/doi.org\/10.1016\/j.celrep.2017.02.004.","journal-title":"Cell Rep"},{"issue":"17","key":"7884_CR44","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1016\/j.molcel.2023.07.030","volume":"83","author":"C Zhao","year":"2023","unstructured":"Zhao C, Wang H, Liu Y, Cheng L, Wang B, Tian X, et al. Biased allosteric activation of ketone body receptor Hcar2 Suppresses inflammation. Mol Cell. 2023;83(17):3171\u201387 e7. Epub 20230818. doi: https:\/\/doi.org\/10.1016\/j.molcel.2023.07.030.","journal-title":"Mol Cell"},{"key":"7884_CR45","doi-asserted-by":"publisher","unstructured":"Zhuang H, Ren X, Zhang Y, Li H, Zhou P. Beta-Hydroxybutyrate Enhances chondrocyte mitophagy and Reduces cartilage degeneration in osteoarthritis via the Hcar2\/Ampk\/Pink1\/Parkin pathway. Aging Cell. 2024;23(11):e14294. Epub 20240809. doi: https:\/\/doi.org\/10.1111\/acel.14294.","DOI":"10.1111\/acel.14294"},{"issue":"2","key":"7884_CR46","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.metabol.2015.10.001","volume":"65","author":"EC Graff","year":"2016","unstructured":"Graff EC, Fang H, Wanders D, Judd RL. Anti-inflammatory effects of the hydroxycarboxylic acid receptor 2. Metabolism. 2016;65(2):102\u201313. Epub 20151113. doi: https:\/\/doi.org\/10.1016\/j.metabol.2015.10.001.","journal-title":"Metabolism"},{"issue":"3","key":"7884_CR47","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.jhep.2018.04.004","volume":"69","author":"Y Chen","year":"2018","unstructured":"Chen Y, Ouyang X, Hoque R, Garcia-Martinez I, Yousaf MN, Tonack S, et al. Beta-Hydroxybutyrate Protects from alcohol-Induced Liver injury via a Hcar2-camp dependent pathway. J Hepatol. 2018;69(3):687\u201396. Epub 20180427. doi: https:\/\/doi.org\/10.1016\/j.jhep.2018.04.004.","journal-title":"J Hepatol"},{"key":"7884_CR48","doi-asserted-by":"publisher","first-page":"3944","DOI":"10.1038\/ncomms4944","volume":"5","author":"M Rahman","year":"2014","unstructured":"Rahman M, Muhammad S, Khan MA, Chen H, Ridder DA, Muller-Fielitz H, et al. The Beta-Hydroxybutyrate receptor Hca2 Activates a neuroprotective subset of macrophages. Nat Commun. 2014;5:3944. Epub 20140521. doi: https:\/\/doi.org\/10.1038\/ncomms4944.","journal-title":"Nat Commun"},{"issue":"1","key":"7884_CR49","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.medj.2020.06.008","volume":"1","author":"BJ Stubbs","year":"2020","unstructured":"Stubbs BJ, Koutnik AP, Goldberg EL, Upadhyay V, Turnbaugh PJ, Verdin E, et al. Investigating ketone bodies as immunometabolic countermeasures against respiratory viral Infections. Med. 2020;1(1):43\u201365. Epub 20200715. doi: https:\/\/doi.org\/10.1016\/j.medj.2020.06.008.","journal-title":"Med"},{"issue":"1","key":"7884_CR50","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12916-022-02352-x","volume":"20","author":"C Huang","year":"2022","unstructured":"Huang C, Wang J, Liu H, Huang R, Yan X, Song M, et al. Ketone body Beta-Hydroxybutyrate Ameliorates Colitis by promoting M2 Macrophage polarization through the Stat6-dependent signaling pathway. BMC Med. 2022;20(1):148. Epub 20220415. doi: https:\/\/doi.org\/10.1186\/s12916-022-02352-x.","journal-title":"BMC Med"},{"issue":"2","key":"7884_CR51","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.cmet.2018.10.015","volume":"29","author":"P Puchalska","year":"2019","unstructured":"Puchalska P, Martin SE, Huang X, Lengfeld JE, Daniel B, Graham MJ, et al. Hepatocyte-Macrophage Acetoacetate shuttle Protects against tissue Fibrosis. Cell Metab. 2019;29(2):383\u201398 e7. Epub 20181115. doi: https:\/\/doi.org\/10.1016\/j.cmet.2018.10.015.","journal-title":"Cell Metab"},{"issue":"4","key":"7884_CR52","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1002\/hep.26134","volume":"57","author":"BV Martin-Murphy","year":"2013","unstructured":"Martin-Murphy BV, Kominsky DJ, Orlicky DJ, Donohue TM Jr, Ju C. Increased susceptibility of natural killer T-Cell-Deficient Mice to acetaminophen-Induced Liver injury. Hepatology. 2013;57(4):1575\u201384. Epub 20130118. doi: https:\/\/doi.org\/10.1002\/hep.26134.","journal-title":"Hepatology"},{"key":"7884_CR53","doi-asserted-by":"publisher","unstructured":"Gonzatti MB, Goldberg EL. Ketone bodies as chemical signals for the immune System. Am J Physiol Cell Physiol. 2024;326(3):C707\u201311. Epub 20240108. doi: https:\/\/doi.org\/10.1152\/ajpcell.00478.2023.","DOI":"10.1152\/ajpcell.00478.2023"},{"issue":"2","key":"7884_CR54","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1039\/d2ay01434c","volume":"15","author":"H He","year":"2023","unstructured":"He H, Song Y, Li M, Zhang H, Li J, Huang H, et al. A novel anthocyanin electrospun film by caffeic acid Co-pigmentation for Real-time fish freshness monitoring. Anal Methods. 2023;15(2):228\u201339. Epub 20230106. doi: https:\/\/doi.org\/10.1039\/d2ay01434c.","journal-title":"Anal Methods"},{"issue":"1","key":"7884_CR55","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41556-019-0440-0","volume":"22","author":"H Zhang","year":"2020","unstructured":"Zhang H, Tang K, Ma J, Zhou L, Liu J, Zeng L, et al. Ketogenesis-generated Beta-Hydroxybutyrate is an epigenetic Regulator of Cd8(+) T-Cell Memory development. Nat Cell Biol. 2020;22(1):18\u201325. Epub 20191223. doi: https:\/\/doi.org\/10.1038\/s41556-019-0440-0.","journal-title":"Nat Cell Biol"},{"issue":"9","key":"7884_CR56","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1016\/j.immuni.2023.07.002","volume":"56","author":"KM Luda","year":"2023","unstructured":"Luda KM, Longo J, Kitchen-Goosen SM, Duimstra LR, Ma EH, Watson MJ, et al. Ketolysis Drives Cd8(+) T Cell effector function through effects on Histone acetylation. Immunity. 2023;56(9):2021\u201335 e8. Epub 20230728. doi: https:\/\/doi.org\/10.1016\/j.immuni.2023.07.002.","journal-title":"Immunity"},{"issue":"7928","key":"7884_CR57","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/s41586-022-05128-8","volume":"609","author":"F Karagiannis","year":"2022","unstructured":"Karagiannis F, Peukert K, Surace L, Michla M, Nikolka F, Fox M, et al. Impaired ketogenesis ties metabolism to T Cell dysfunction in Covid-19. Nature. 2022;609(7928):801\u201307. Epub 20220728. doi: https:\/\/doi.org\/10.1038\/s41586-022-05128-8.","journal-title":"Nature"},{"key":"7884_CR58","doi-asserted-by":"publisher","unstructured":"Hirschberger S, Strauss G, Effinger D, Marstaller X, Ferstl A, Muller MB, et al. Very-Low-Carbohydrate Diet Enhances Human T-Cell Immunity through immunometabolic reprogramming. EMBO Mol Med. 2021;13(8):e14323. Epub 20210621. doi: https:\/\/doi.org\/10.15252\/emmm.202114323.","DOI":"10.15252\/emmm.202114323"},{"issue":"4","key":"7884_CR59","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/bjh.18293","volume":"198","author":"J Qin","year":"2022","unstructured":"Qin J, Liu Q, Liu A, Leng S, Wang S, Li C, et al. Empagliflozin Modulates Cd4(+) T-Cell differentiation via metabolic reprogramming in immune thrombocytopenia. Br J Haematol. 2022;198(4):765\u201375. Epub 20220608. doi: https:\/\/doi.org\/10.1111\/bjh.18293.","journal-title":"Br J Haematol"},{"key":"7884_CR60","doi-asserted-by":"publisher","unstructured":"Dabek A, Wojtala M, Pirola L, Balcerczyk A. Modulation of cellular Biochemistry, Epigenetics and metabolomics by ketone bodies. Implications of the Ketogenic Diet in the Physiology of the organism and pathological states. Nutrients. 2020;12(3). Epub 20200317. doi: https:\/\/doi.org\/10.3390\/nu12030788.","DOI":"10.3390\/nu12030788"},{"key":"7884_CR61","doi-asserted-by":"publisher","first-page":"923502","DOI":"10.3389\/fmed.2022.923502","volume":"9","author":"S Hirschberger","year":"2022","unstructured":"Hirschberger S, Gellert L, Effinger D, Muenchhoff M, Herrmann M, Briegel JM, et al. Ketone bodies improve Human Cd8(+) cytotoxic T-Cell immune Response during Covid-19 infection. Front Med (Lausanne). 2022;9:923502. Epub 20220616. doi: https:\/\/doi.org\/10.3389\/fmed.2022.923502.","journal-title":"Front Med (Lausanne)"},{"issue":"9","key":"7884_CR62","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.cmet.2022.07.012","volume":"34","author":"I Kaymak","year":"2022","unstructured":"Kaymak I, Luda KM, Duimstra LR, Ma EH, Longo J, Dahabieh MS, et al. Carbon source availability Drives nutrient utilization in Cd8(+) T cells. Cell Metab. 2022;34(9):1298\u2013311 e6. Epub 20220817. doi: https:\/\/doi.org\/10.1016\/j.cmet.2022.07.012.","journal-title":"Cell Metab"},{"issue":"11","key":"7884_CR63","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1016\/j.cmet.2024.10.009","volume":"36","author":"W Liu","year":"2024","unstructured":"Liu W, You D, Lin J, Zou H, Zhang L, Luo S, et al. Sglt2 Inhibitor promotes ketogenesis to improve mash by Suppressing Cd8(+) T Cell activation. Cell Metab. 2024;36(11):2489. Epub 20241016. doi: https:\/\/doi.org\/10.1016\/j.cmet.2024.10.009.","journal-title":"Cell Metab"},{"key":"7884_CR64","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.3389\/fimmu.2019.02716","volume":"10","author":"H Shi","year":"2019","unstructured":"Shi H, Chi H. Metabolic Control of Treg Cell stability, Plasticity, and tissue-specific Heterogeneity. Front Immunol. 2019;10:2716. Epub 20191211. doi: https:\/\/doi.org\/10.3389\/fimmu.2019.02716.","journal-title":"Front Immunol"},{"issue":"7","key":"7884_CR65","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1007\/s00394-024-03469-w","volume":"63","author":"A Ferrari","year":"2024","unstructured":"Ferrari A, Filoni J, Di Dedda C, Piemonti L, Monti P. Ketone bodies Rescue T Cell impairments Induced by Low Glucose availability. Eur J Nutr. 2024;63(7):2815\u201325. Epub 20240806. doi: https:\/\/doi.org\/10.1007\/s00394-024-03469-w.","journal-title":"Eur J Nutr"},{"issue":"1","key":"7884_CR66","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/s12974-024-03308-z","volume":"21","author":"R Duan","year":"2024","unstructured":"Duan R, Wang T, Li Z, Jiang L, Yu X, He D, et al. Ketogenic Diet Modulates immune Cell transcriptional landscape and Ameliorates experimental autoimmune uveitis in Mice. J Neuroinflammation. 2024;21(1):319. Epub 20241203. doi: https:\/\/doi.org\/10.1186\/s12974-024-03308-z.","journal-title":"J Neuroinflammation"},{"key":"7884_CR67","doi-asserted-by":"publisher","unstructured":"Zhang Q, Sun W, Wang Q, Zheng X, Zhang R, Zhang N. A High mct-based Ketogenic Diet Suppresses Th1 and Th17 responses to ameliorate experimental autoimmune encephalomyelitis in Mice by Inhibiting gsdmd and Jak2-Stat3\/4 pathways. Mol Nutr Food Res. 2024;68(3):e2300602. Epub 20231206. doi: https:\/\/doi.org\/10.1002\/mnfr.202300602.","DOI":"10.1002\/mnfr.202300602"},{"key":"7884_CR68","doi-asserted-by":"publisher","unstructured":"Hao F, Tian M, Wang H, Li S, Wang X, Jin X, et al. Exercise-Induced Beta-Hydroxybutyrate promotes Treg Cell differentiation to ameliorate Colitis in Mice. Faseb J. 2024;38(4):e23487. https:\/\/doi.org\/10.1096\/fj.202301686RR.","DOI":"10.1096\/fj.202301686RR"},{"issue":"7","key":"7884_CR69","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1208\/s12249-023-02633-5","volume":"24","author":"N Panse","year":"2023","unstructured":"Panse N, Halquist M, Gerk PM. Quantitative determination of (R)-3-hydroxybutyl (R)-3-Hydroxybutyrate (ketone Ester) and its Metabolites Beta-Hydroxybutyrate, 1-3-Butanediol, and Acetoacetate in Human plasma Using lc-Ms. AAPS PharmSciTech. 2023;24(7):184. Epub 20230912. doi: https:\/\/doi.org\/10.1208\/s12249-023-02633-5.","journal-title":"AAPS PharmSciTech"},{"key":"7884_CR70","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3389\/fnut.2019.00056","volume":"6","author":"SE Deemer","year":"2019","unstructured":"Deemer SE, Davis RAH, Gower BA, Koutnik AP, Poff AM, Dickinson SL, et al. Concentration-dependent effects of a dietary ketone Ester on components of energy balance in Mice. Front Nutr. 2019;6:56. Epub 20190501. doi: https:\/\/doi.org\/10.3389\/fnut.2019.00056.","journal-title":"Front Nutr"},{"key":"7884_CR71","doi-asserted-by":"publisher","unstructured":"Zhang K, Zhang H, Yi H, Huang G, Zhao X, Yu S, et al. The Protective effects of 1, 3-Butanediol Acetoacetate diester on decompression sickness in Rats. J Appl Physiol (1985) 2021;131(2):435\u201341. Epub 20210624. https:\/\/doi.org\/10.1152\/japplphysiol.00035.2021.","DOI":"10.1152\/japplphysiol.00035.2021."},{"key":"7884_CR72","doi-asserted-by":"publisher","first-page":"1165224","DOI":"10.3389\/fphys.2023.1165224","volume":"14","author":"KA Rushing","year":"2023","unstructured":"Rushing KA, Bolyard ML, Kelty T, Wieschhaus N, Pavela G, Rector RS, et al. Dietary ketone Ester Attenuates the accretion of adiposity and Liver Steatosis in Mice Fed a High-Fat, High-sugar Diet. Front Physiol. 2023;14:1165224. Epub 20230411. doi: https:\/\/doi.org\/10.3389\/fphys.2023.1165224.","journal-title":"Front Physiol"},{"key":"7884_CR73","doi-asserted-by":"publisher","unstructured":"Falkenhain K, Oliveira BF, Islam H, Neudorf H, Cen HH, Johnson JD, et al. The Effect of Acute and 14-day exogenous ketone supplementation on glycemic Control in adults with type 2 Diabetes: two Randomized controlled trials. Am J Physiol Endocrinol Metab. 2024;326(1):E61\u201372. Epub 20231122. doi: https:\/\/doi.org\/10.1152\/ajpendo.00332.2023.","DOI":"10.1152\/ajpendo.00332.2023"},{"key":"7884_CR74","doi-asserted-by":"publisher","unstructured":"Bolyard ML, Graziano CM, Fontaine KR, Sayer RD, Fisher G, Plaisance EP. Tolerability and acceptability of an exogenous ketone Monoester and ketone Monoester\/Salt formulation in Humans. Nutrients. 2023;15(23). Epub 20231122. doi: https:\/\/doi.org\/10.3390\/nu15234876.","DOI":"10.3390\/nu15234876"},{"issue":"5","key":"7884_CR75","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.cell.2019.07.050","volume":"178","author":"S Jordan","year":"2019","unstructured":"Jordan S, Tung N, Casanova-Acebes M, Chang C, Cantoni C, Zhang D, et al. Dietary intake regulates the circulating inflammatory monocyte pool. Cell. 2019;178(5):1102\u201314 e17. https:\/\/doi.org\/10.1016\/j.cell.2019.07.050.","journal-title":"Cell"},{"issue":"9","key":"7884_CR76","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.tem.2024.04.014","volume":"35","author":"DM Marko","year":"2024","unstructured":"Marko DM, Conn MO, Schertzer JD. Intermittent Fasting influences Immunity and metabolism. Trends Endocrinol Metab. 2024;35(9):821\u201333. Epub 20240508. doi: https:\/\/doi.org\/10.1016\/j.tem.2024.04.014.","journal-title":"Trends Endocrinol Metab"},{"key":"7884_CR77","doi-asserted-by":"publisher","unstructured":"Lv M, Zhu X, Wang H, Wang F, Guan W. Roles of caloric restriction, Ketogenic Diet and Intermittent Fasting during Initiation, progression and metastasis of Cancer in Animal models: a Systematic Review and Meta-Analysis. PLoS One. 2014;9(12):e115147. Epub 20141211. doi: https:\/\/doi.org\/10.1371\/journal.pone.0115147.","DOI":"10.1371\/journal.pone.0115147"},{"issue":"1","key":"7884_CR78","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12974-022-02474-2","volume":"19","author":"S Dai","year":"2022","unstructured":"Dai S, Wei J, Zhang H, Luo P, Yang Y, Jiang X, et al. Intermittent Fasting Reduces Neuroinflammation in intracerebral hemorrhage through the Sirt3\/Nrf2\/Ho-1 pathway. J Neuroinflammation. 2022;19(1):122. Epub 20220527. doi: https:\/\/doi.org\/10.1186\/s12974-022-02474-2.","journal-title":"J Neuroinflammation"},{"key":"7884_CR79","doi-asserted-by":"publisher","first-page":"102274","DOI":"10.1016\/j.arr.2024.102274","volume":"96","author":"O Strilbytska","year":"2024","unstructured":"Strilbytska O, Klishch S, Storey KB, Koliada A, Lushchak O. Intermittent Fasting and longevity: from Animal models to implication for Humans. Ageing Res Rev. 2024;96:102274. Epub 20240317. doi: https:\/\/doi.org\/10.1016\/j.arr.2024.102274.","journal-title":"Ageing Res Rev"},{"issue":"5","key":"7884_CR80","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.2337\/db15-1356","volume":"65","author":"E Ferrannini","year":"2016","unstructured":"Ferrannini E, Baldi S, Frascerra S, Astiarraga B, Heise T, Bizzotto R, et al. Shift to fatty substrate utilization in Response to Sodium-Glucose Cotransporter 2 inhibition in Subjects without Diabetes and Patients with type 2 Diabetes. Diabetes. 2016;65(5):1190\u201395. Epub 20160209. doi: https:\/\/doi.org\/10.2337\/db15-1356.","journal-title":"Diabetes"},{"issue":"4","key":"7884_CR81","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s10787-021-00818-7","volume":"29","author":"MA El-Rous","year":"2021","unstructured":"El-Rous MA, Saber S, Raafat EM, Ahmed AAE. Dapagliflozin, an Sglt2 Inhibitor, Ameliorates acetic acid-Induced Colitis in Rats by targeting Nfkappab\/Ampk\/Nlrp3 axis. Inflammopharmacology. 2021;29(4):1169\u201385. Epub 20210517. doi: https:\/\/doi.org\/10.1007\/s10787-021-00818-7.","journal-title":"Inflammopharmacology"},{"issue":"24","key":"7884_CR82","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","volume":"380","author":"V Perkovic","year":"2019","unstructured":"Perkovic V, Jardine MJ, Neal B, Bompoint S, Heerspink HJL, Charytan DM, et al. Canagliflozin and renal Outcomes in type 2 Diabetes and nephropathy. N Engl J Med. 2019;380(24):2295\u2013306. Epub 20190414. doi: https:\/\/doi.org\/10.1056\/NEJMoa1811744.","journal-title":"N Engl J Med"},{"issue":"10166","key":"7884_CR83","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(18)32590-X","volume":"393","author":"TA Zelniker","year":"2019","unstructured":"Zelniker TA, Wiviott SD, Raz I, Im K, Goodrich EL, Bonaca MP, et al. Sglt2 inhibitors for primary and secondary Prevention of Cardiovascular and renal Outcomes in type 2 Diabetes: a Systematic Review and Meta-Analysis of Cardiovascular outcome trials. Lancet. 2019;393(10166):31\u201339. Epub 20181110. doi: https:\/\/doi.org\/10.1016\/S0140-6736(18)32590-X.","journal-title":"Lancet"},{"issue":"4","key":"7884_CR84","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.molmet.2014.02.002","volume":"3","author":"S Kersten","year":"2014","unstructured":"Kersten S. Integrated Physiology and Systems biology of Pparalpha. Mol Metab. 2014;3(4):354\u201371. Epub 20140306. doi: https:\/\/doi.org\/10.1016\/j.molmet.2014.02.002.","journal-title":"Mol Metab"},{"issue":"4","key":"7884_CR85","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41580-022-00547-x","volume":"24","author":"GR Steinberg","year":"2023","unstructured":"Steinberg GR, Hardie DG. New Insights into activation and function of the Ampk. Nat Rev Mol Cell Biol. 2023;24(4):255\u201372. Epub 20221031. doi: https:\/\/doi.org\/10.1038\/s41580-022-00547-x.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"7884_CR86","doi-asserted-by":"publisher","first-page":"36842","DOI":"10.1038\/s41598-025-20731-1","volume":"15","author":"VR Pannala","year":"2025","unstructured":"Pannala VR, Balik-Meisner MR, Mav D, Phadke DP, Scholl EH, Shah RR, et al. Fenofibrate differentially Activates Pparalpha-mediated Lipid metabolism in rat Kidney and Liver. Sci Rep. 2025;15(1):36842. Epub 20251022. doi: https:\/\/doi.org\/10.1038\/s41598-025-20731-1.","journal-title":"Sci Rep"},{"issue":"1","key":"7884_CR87","doi-asserted-by":"publisher","first-page":"23816","DOI":"10.1038\/s41598-024-74340-5","volume":"14","author":"Y Shinkai","year":"2024","unstructured":"Shinkai Y, Sasaki K, Tamura R, Ike T, Takahashi A, Osaki Y, et al. Selective activation of Pparalpha by Pemafibrate Mitigates peritoneal inflammation and Fibrosis through Suppression of Nlrp3 inflammasome and modulation of inflammation. Sci Rep. 2024;14(1):23816. Epub 20241011. doi: https:\/\/doi.org\/10.1038\/s41598-024-74340-5.","journal-title":"Sci Rep"},{"issue":"5","key":"7884_CR88","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1210\/er.2018-00064","volume":"39","author":"N Bougarne","year":"2018","unstructured":"Bougarne N, Weyers B, Desmet SJ, Deckers J, Ray DW, Staels B, et al. Molecular actions of Pparalpha in Lipid metabolism and inflammation. Endocr Rev. 2018;39(5):760\u2013802. https:\/\/doi.org\/10.1210\/er.2018-00064.","journal-title":"Endocr Rev"},{"issue":"2","key":"7884_CR89","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1210\/jc.2009-1487","volume":"95","author":"R Belfort","year":"2010","unstructured":"Belfort R, Berria R, Cornell J, Cusi K. Fenofibrate Reduces systemic inflammation markers Independent of its effects on Lipid and Glucose metabolism in Patients with the metabolic Syndrome. J Clin Endocrinol Metab. 2010;95(2):829\u201336. Epub 20100108. doi: https:\/\/doi.org\/10.1210\/jc.2009-1487.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"7884_CR90","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.jhep.2024.05.007","volume":"81","author":"CX Zhu","year":"2024","unstructured":"Zhu CX, Yan K, Chen L, Huang RR, Bian ZH, Wei HR, et al. Targeting Oxct1-mediated ketone metabolism Reprograms macrophages to promote antitumor Immunity via Cd8(+) T cells in hepatocellular carcinoma. J Hepatol. 2024;81(4):690\u2013703. Epub 20240515. doi: https:\/\/doi.org\/10.1016\/j.jhep.2024.05.007.","journal-title":"J Hepatol"},{"issue":"5","key":"7884_CR91","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.cmet.2020.03.017","volume":"31","author":"R Al Batran","year":"2020","unstructured":"Al Batran R, Gopal K, Capozzi ME, Chahade JJ, Saleme B, Tabatabaei-Dakhili SA, et al. Pimozide alleviates Hyperglycemia in Diet-Induced Obesity by Inhibiting skeletal Muscle ketone oxidation. Cell Metab. 2020;31(5):909\u201319 e8. Epub 20200409. doi: https:\/\/doi.org\/10.1016\/j.cmet.2020.03.017.","journal-title":"Cell Metab"},{"issue":"4","key":"7884_CR92","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s10741-023-10295-5","volume":"28","author":"X Wang","year":"2023","unstructured":"Wang X, Huang Y, Zhang K, Chen F, Nie T, Zhao Y, et al. Changes of energy metabolism in failing Heart and its regulation by Sirt3. Heart Fail Rev. 2023;28(4):977\u201392. Epub 20230128. doi: https:\/\/doi.org\/10.1007\/s10741-023-10295-5.","journal-title":"Heart Fail Rev"},{"issue":"1","key":"7884_CR93","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s11064-018-2588-6","volume":"44","author":"MM Hasan-Olive","year":"2019","unstructured":"Hasan-Olive MM, Lauritzen KH, Ali M, Rasmussen LJ, Storm-Mathisen J, Bergersen LH. A Ketogenic Diet Improves mitochondrial biogenesis and bioenergetics via the Pgc1alpha-Sirt3-Ucp2 axis. Neurochem Res. 2019;44(1):22\u201337. Epub 20180719. doi: https:\/\/doi.org\/10.1007\/s11064-018-2588-6.","journal-title":"Neurochem Res"},{"issue":"6","key":"7884_CR94","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.cmet.2010.11.003","volume":"12","author":"T Shimazu","year":"2010","unstructured":"Shimazu T, Hirschey MD, Hua L, Dittenhafer-Reed KE, Schwer B, Lombard DB, et al. Sirt3 deacetylates mitochondrial 3-Hydroxy-3-Methylglutaryl Coa synthase 2 and regulates ketone body production. Cell Metab. 2010;12(6):654\u201361. https:\/\/doi.org\/10.1016\/j.cmet.2010.11.003.","journal-title":"Cell Metab"},{"issue":"7","key":"7884_CR95","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.7150\/ijbs.110921","volume":"21","author":"M Deng","year":"2025","unstructured":"Deng M, Fang Y, Chu Y, Ding R, Fan X, Wei H, et al. Sirt3 is required for the Protective function of Ketogenic Diet on neural inflammation and neuropathic pain. Int J Biol Sci. 2025;21(7):3011\u201329. Epub 20250421. doi: https:\/\/doi.org\/10.7150\/ijbs.110921.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"7884_CR96","doi-asserted-by":"publisher","first-page":"5046","DOI":"10.1038\/s41467-024-49092-5","volume":"15","author":"MM McDermott","year":"2024","unstructured":"McDermott MM, Martens CR, Domanchuk KJ, Zhang D, Peek CB, Criqui MH, et al. Nicotinamide Riboside for Peripheral artery Disease: the nice Randomized clinical Trial. Nat Commun. 2024;15(1):5046. Epub 20240613. doi: https:\/\/doi.org\/10.1038\/s41467-024-49092-5.","journal-title":"Nat Commun"},{"issue":"6","key":"7884_CR97","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.advnut.2023.08.008","volume":"14","author":"Q Song","year":"2023","unstructured":"Song Q, Zhou X, Xu K, Liu S, Zhu X, Yang J. The safety and antiaging effects of Nicotinamide mononucleotide in Human clinical trials: an Update. Adv Nutr. 2023;14(6):1416\u201335. Epub 20230822. doi: https:\/\/doi.org\/10.1016\/j.advnut.2023.08.008.","journal-title":"Adv Nutr"},{"key":"7884_CR98","doi-asserted-by":"publisher","unstructured":"Ma S, Suzuki K. Keto-adaptation and Endurance exercise capacity, fatigue recovery, and exercise-Induced Muscle and Organ damage Prevention: a narrative Review. Sports (Basel). 2019;7(2). Epub 20190213. doi: https:\/\/doi.org\/10.3390\/sports7020040.","DOI":"10.3390\/sports7020040"},{"issue":"9","key":"7884_CR99","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1113\/JP273185","volume":"595","author":"M Evans","year":"2017","unstructured":"Evans M, Cogan KE, Egan B. Metabolism of ketone bodies during exercise and training: physiological basis for exogenous supplementation. J Physiol. 2017;595(9):2857\u201371. Epub 20161207. doi: https:\/\/doi.org\/10.1113\/JP273185.","journal-title":"J Physiol"},{"key":"7884_CR100","doi-asserted-by":"publisher","first-page":"101494","DOI":"10.1016\/j.molmet.2022.101494","volume":"61","author":"S Asif","year":"2022","unstructured":"Asif S, Kim RY, Fatica T, Sim J, Zhao X, Oh Y, et al. Hmgcs2-mediated ketogenesis Modulates High-Fat Diet-Induced hepatosteatosis. Mol Metab. 2022;61:101494. Epub 20220412. doi: https:\/\/doi.org\/10.1016\/j.molmet.2022.101494.","journal-title":"Mol Metab"},{"key":"7884_CR101","doi-asserted-by":"publisher","unstructured":"Moore MP, Cunningham RP, Davis RAH, Deemer SE, Roberts BM, Plaisance EP, et al. A dietary ketone Ester Mitigates histological Outcomes of Nafld and markers of Fibrosis in High-Fat Diet Fed Mice. Am J Physiol Gastrointest Liver Physiol. 2021;320(4):G564\u201372. Epub 20210127. doi: https:\/\/doi.org\/10.1152\/ajpgi.00259.2020.","DOI":"10.1152\/ajpgi.00259.2020"},{"issue":"3","key":"7884_CR102","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/s0899-9007(96)00409-1","volume":"13","author":"H Brunengraber","year":"1997","unstructured":"Brunengraber H. Potential of ketone body esters for parenteral and oral Nutrition. Nutrition. 1997;13(3):233\u201335. https:\/\/doi.org\/10.1016\/s0899-9007(96)00409-1.","journal-title":"Nutrition"},{"key":"7884_CR103","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3389\/fnmol.2016.00137","volume":"9","author":"C Ari","year":"2016","unstructured":"Ari C, Kovacs Z, Juhasz G, Murdun C, Goldhagen CR, Koutnik AP, et al. Exogenous ketone Supplements reduce anxiety-Related behavior in Sprague-Dawley and wistar albino Glaxo\/Rijswijk Rats. Front Mol Neurosci. 2016;9:137. Epub 20161206. doi: https:\/\/doi.org\/10.3389\/fnmol.2016.00137.","journal-title":"Front Mol Neurosci"},{"issue":"7","key":"7884_CR104","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1002\/ijc.28809","volume":"135","author":"AM Poff","year":"2014","unstructured":"Poff AM, Ari C, Arnold P, Seyfried TN, D\u2019Agostino DP. Ketone supplementation decreases Tumor Cell viability and prolongs survival of Mice with metastatic Cancer. Int J Cancer. 2014;135(7):1711\u201320. Epub 20140514. doi: https:\/\/doi.org\/10.1002\/ijc.28809.","journal-title":"Int J Cancer"},{"issue":"3","key":"7884_CR105","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.cmet.2018.01.005","volume":"27","author":"A Mardinoglu","year":"2018","unstructured":"Mardinoglu A, Wu H, Bjornson E, Zhang C, Hakkarainen A, Rasanen SM, et al. An integrated understanding of the rapid metabolic benefits of a Carbohydrate-restricted Diet on hepatic Steatosis in Humans. Cell Metab. 2018;27(3):559\u201371 e5. Epub 20180215. doi: https:\/\/doi.org\/10.1016\/j.cmet.2018.01.005.","journal-title":"Cell Metab"},{"issue":"2","key":"7884_CR106","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s10620-006-9433-5","volume":"52","author":"D Tendler","year":"2007","unstructured":"Tendler D, Lin S, Yancy WS Jr, Mavropoulos J, Sylvestre P, Rockey DC, et al. The Effect of a Low-Carbohydrate, Ketogenic Diet on Nonalcoholic fatty Liver Disease: a Pilot Study. Dig Dis Sci. 2007;52(2):589\u201393. Epub 20070112. doi: https:\/\/doi.org\/10.1007\/s10620-006-9433-5.","journal-title":"Dig Dis Sci"},{"issue":"13","key":"7884_CR107","doi-asserted-by":"publisher","first-page":"7347","DOI":"10.1073\/pnas.1922344117","volume":"117","author":"PK Luukkonen","year":"2020","unstructured":"Luukkonen PK, Dufour S, Lyu K, Zhang XM, Hakkarainen A, Lehtimaki TE, et al. Effect of a Ketogenic Diet on hepatic Steatosis and hepatic mitochondrial metabolism in Nonalcoholic fatty Liver Disease. Proc Natl Acad Sci U S A. 2020;117(13):7347\u201354. Epub 20200316. doi: https:\/\/doi.org\/10.1073\/pnas.1922344117.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7884_CR108","doi-asserted-by":"publisher","unstructured":"Nomura M, Murad NF, Madhavan SS, Mu WC, Eap B, Garcia TY, et al. Ketogenic Diet Reduces Age-Induced chronic Neuroinflammation in Mice. Aging Biol. 2024;2. Epub 20241216. doi: https:\/\/doi.org\/10.59368\/agingbio.20240038.","DOI":"10.59368\/agingbio.20240038"},{"issue":"2","key":"7884_CR109","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.jaci.2015.06.038","volume":"137","author":"P Nagakumar","year":"2016","unstructured":"Nagakumar P, Denney L, Fleming L, Bush A, Lloyd CM, Saglani S. Type 2 innate lymphoid cells in Induced sputum from Children with Severe asthma. J Allergy Clin Immunol. 2016;137(2):624\u20136 e6. Epub 20150812. doi: https:\/\/doi.org\/10.1016\/j.jaci.2015.06.038.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"7884_CR110","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jaci.2015.05.037","volume":"137","author":"SG Smith","year":"2016","unstructured":"Smith SG, Chen R, Kjarsgaard M, Huang C, Oliveria JP, O\u2019Byrne PM, et al. Increased Numbers of Activated group 2 innate lymphoid cells in the airways of Patients with Severe asthma and persistent Airway Eosinophilia. J Allergy Clin Immunol. 2016;137(1):75\u201386 e8. Epub 20150717. doi: https:\/\/doi.org\/10.1016\/j.jaci.2015.05.037.","journal-title":"J Allergy Clin Immunol"},{"key":"7884_CR111","doi-asserted-by":"publisher","first-page":"101774","DOI":"10.1016\/j.ctcp.2023.101774","volume":"52","author":"Q Yu","year":"2023","unstructured":"Yu Q, Falkenhain K, Little JP, Wong KK, Nie J, Shi Q, et al. Effects of ketone Supplements on blood Beta-Hydroxybutyrate, Glucose and insulin: A Systematic Review and three-level Meta-Analysis. Complement Ther Clin Pract. 2023;52:101774. Epub 20230610. doi: https:\/\/doi.org\/10.1016\/j.ctcp.2023.101774.","journal-title":"Complement Ther Clin Pract"},{"key":"7884_CR112","doi-asserted-by":"publisher","first-page":"1048230","DOI":"10.3389\/fnut.2023.1048230","volume":"10","author":"Z He","year":"2023","unstructured":"He Z, Xu H, Li C, Yang H, Mao Y. Intermittent Fasting and immunomodulatory effects: a Systematic Review. Front Nutr. 2023;10:1048230. Epub 20230228. doi: https:\/\/doi.org\/10.3389\/fnut.2023.1048230.","journal-title":"Front Nutr"},{"key":"7884_CR113","doi-asserted-by":"publisher","unstructured":"Udumula MP, Singh H, Faraz R, Poisson L, Tiwari N, Dimitrova I, et al. Intermittent Fasting Induced ketogenesis inhibits mouse epithelial ovarian tumors by promoting anti-Tumor T Cell Response. bioRxiv. 2023). Epub 20230310. doi: https:\/\/doi.org\/10.1101\/2023.03.08.531740.","DOI":"10.1101\/2023.03.08.531740"},{"issue":"1","key":"7884_CR114","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12937-024-01046-9","volume":"23","author":"ZA Rizvi","year":"2024","unstructured":"Rizvi ZA, Saleem J, Zeb I, Shahzad R, Kayani JA, Faryal J, et al. Effects of Intermittent Fasting on body composition, clinical Health markers and Memory status in the Adult Population: a single-blind randomised controlled Trial. Nutr J. 2024;23(1):147. Epub 20241128. doi: https:\/\/doi.org\/10.1186\/s12937-024-01046-9.","journal-title":"Nutr J"},{"key":"7884_CR115","doi-asserted-by":"publisher","unstructured":"Osataphan S, Macchi C, Singhal G, Chimene-Weiss J, Sales V, Kozuka C, et al. Sglt2 inhibition Reprograms systemic metabolism via Fgf21-dependent and -Independent mechanisms. JCI Insight. 2019;4(5). Epub 20190307. doi: https:\/\/doi.org\/10.1172\/jci.insight.123130.","DOI":"10.1172\/jci.insight.123130"},{"issue":"3","key":"7884_CR116","doi-asserted-by":"publisher","first-page":"100176","DOI":"10.1016\/j.jlr.2022.100176","volume":"63","author":"K Wallenius","year":"2022","unstructured":"Wallenius K, Kroon T, Hagstedt T, Lofgren L, Sorhede-Winzell M, Boucher J, et al. The Sglt2 Inhibitor Dapagliflozin promotes systemic ffa mobilization, Enhances hepatic Beta-oxidation, and Induces ketosis. J Lipid Res. 2022;63(3):100176. Epub 20220202. doi: https:\/\/doi.org\/10.1016\/j.jlr.2022.100176.","journal-title":"J Lipid Res"},{"issue":"4","key":"7884_CR117","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.jacc.2019.11.031","volume":"75","author":"TA Zelniker","year":"2020","unstructured":"Zelniker TA, Braunwald E. Mechanisms of Cardiorenal effects of Sodium-Glucose Cotransporter 2 inhibitors: jacc state-of-the-art Review. J Am Coll Cardiol. 2020;75(4):422\u201334. https:\/\/doi.org\/10.1016\/j.jacc.2019.11.031.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"7884_CR118","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s11886-015-0607-7","volume":"17","author":"MO Gore","year":"2015","unstructured":"Gore MO, McGuire DK, Lingvay I, Rosenstock J. Predicting Cardiovascular risk in type 2 Diabetes: the Heterogeneity challenges. Curr Cardiol Rep. 2015;17(7):607. https:\/\/doi.org\/10.1007\/s11886-015-0607-7.","journal-title":"Curr Cardiol Rep"},{"issue":"22","key":"7884_CR119","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, et al. Empagliflozin, Cardiovascular Outcomes, and mortality in type 2 Diabetes. N Engl J Med. 2015;373(22):2117\u201328. Epub 20150917. doi: https:\/\/doi.org\/10.1056\/NEJMoa1504720.","journal-title":"N Engl J Med"},{"issue":"1","key":"7884_CR120","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12933-021-01266-x","volume":"20","author":"B Xiang","year":"2021","unstructured":"Xiang B, Zhao X, Zhou X. Cardiovascular benefits of Sodium-Glucose Cotransporter 2 inhibitors in Diabetic and Nondiabetic Patients. Cardiovasc Diabetol. 2021;20(1):78. Epub 20210407. doi: https:\/\/doi.org\/10.1186\/s12933-021-01266-x.","journal-title":"Cardiovasc Diabetol"},{"key":"7884_CR121","doi-asserted-by":"publisher","unstructured":"Small AM, Wiviott SD. Cardiovascular and renal benefits of Sodium-Glucose Cotransporter-2 inhibitors: pathophysiologic mechanisms and clinical evidence. Minerva Cardiol Angiol. 2024). Epub 20241120. doi: https:\/\/doi.org\/10.23736\/S2724-5683.24.06600-6.","DOI":"10.23736\/S2724-5683.24.06600-6"},{"key":"7884_CR122","doi-asserted-by":"publisher","first-page":"104870","DOI":"10.1016\/j.phrs.2020.104870","volume":"158","author":"CN Koyani","year":"2020","unstructured":"Koyani CN, Plastira I, Sourij H, Hallstrom S, Schmidt A, Rainer PP, et al. Empagliflozin Protects Heart from inflammation and energy depletion via Ampk activation. Pharmacol Res. 2020;158:104870. Epub 20200517. doi: https:\/\/doi.org\/10.1016\/j.phrs.2020.104870.","journal-title":"Pharmacol Res"},{"key":"7884_CR123","doi-asserted-by":"publisher","first-page":"1145587","DOI":"10.3389\/fphar.2023.1145587","volume":"14","author":"S Yang","year":"2023","unstructured":"Yang S, Liu Y, Zhang S, Wu F, Liu D, Wu Q, et al. Risk of Diabetic ketoacidosis of Sglt2 inhibitors in Patients with type 2 Diabetes: a Systematic Review and Network Meta-Analysis of Randomized controlled trials. Front Pharmacol. 2023;14:1145587. Epub 20230613. doi: https:\/\/doi.org\/10.3389\/fphar.2023.1145587.","journal-title":"Front Pharmacol"},{"key":"7884_CR124","doi-asserted-by":"publisher","unstructured":"Chow E, Clement S, Garg R. Euglycemic Diabetic ketoacidosis in the Era of Sglt-2 inhibitors. BMJ Open Diabetes Res Care. 2023;11(5). https:\/\/doi.org\/10.1136\/bmjdrc-2023-003666.","DOI":"10.1136\/bmjdrc-2023-003666"},{"issue":"30","key":"7884_CR125","doi-asserted-by":"publisher","first-page":"27950","DOI":"10.1074\/jbc.M100258200","volume":"276","author":"MH Hsu","year":"2001","unstructured":"Hsu MH, Savas U, Griffin KJ, Johnson EF. Identification of Peroxisome Proliferator-responsive Human Genes by elevated expression of the Peroxisome Proliferator-Activated receptor Alpha in Hepg2 cells. J Biol Chem. 2001;276(30):27950\u201358. Epub 20010522. doi: https:\/\/doi.org\/10.1074\/jbc.M100258200.","journal-title":"J Biol Chem"},{"key":"7884_CR126","doi-asserted-by":"publisher","unstructured":"Todisco S, Santarsiero A, Convertini P, De Stefano G, Gilio M, Iacobazzi V, et al. Ppar Alpha as a metabolic modulator of the Liver: role in the Pathogenesis of Nonalcoholic steatohepatitis (Nash). Biol (Basel). 2022;11(5). Epub 20220523. doi: https:\/\/doi.org\/10.3390\/biology11050792.","DOI":"10.3390\/biology11050792"},{"issue":"3","key":"7884_CR127","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.dld.2007.10.002","volume":"40","author":"C Fernandez-Miranda","year":"2008","unstructured":"Fernandez-Miranda C, Perez-Carreras M, Colina F, Lopez-Alonso G, Vargas C, Solis-Herruzo JA. A Pilot Trial of Fenofibrate for the Treatment of Non-Alcoholic fatty Liver Disease. Dig Liver Dis. 2008;40(3):200\u201305. https:\/\/doi.org\/10.1016\/j.dld.2007.10.002.","journal-title":"Dig Liver Dis"},{"issue":"6","key":"7884_CR128","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1210\/jc.2009-2622","volume":"95","author":"E Fabbrini","year":"2010","unstructured":"Fabbrini E, Mohammed BS, Korenblat KM, Magkos F, McCrea J, Patterson BW, et al. Effect of Fenofibrate and niacin on intrahepatic triglyceride content, Very Low-density lipoprotein kinetics, and insulin Action in Obese Subjects with Nonalcoholic fatty Liver Disease. J Clin Endocrinol Metab. 2010;95(6):2727\u201335. Epub 20100406. doi: https:\/\/doi.org\/10.1210\/jc.2009-2622.","journal-title":"J Clin Endocrinol Metab"},{"key":"7884_CR129","doi-asserted-by":"publisher","unstructured":"Davidson MH, Armani A, McKenney JM, Jacobson TA. Safety considerations with fibrate Therapy. Am J Cardiol. 2007;99(6A):3C\u201318C. Epub 20061208. doi: https:\/\/doi.org\/10.1016\/j.amjcard.2006.11.016.","DOI":"10.1016\/j.amjcard.2006.11.016"},{"issue":"1","key":"7884_CR130","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1748-1716.2009.01970.x","volume":"196","author":"B Viollet","year":"2009","unstructured":"Viollet B, Guigas B, Leclerc J, Hebrard S, Lantier L, Mounier R, et al. Amp-Activated protein kinase in the regulation of hepatic energy metabolism: from Physiology to therapeutic Perspectives. Acta Physiol (Oxf). 2009;196(1):81\u201398. Epub 20090219. doi: https:\/\/doi.org\/10.1111\/j.1748-1716.2009.01970.x.","journal-title":"Acta Physiol (Oxf)"},{"key":"7884_CR131","doi-asserted-by":"publisher","unstructured":"Foretz M, Even PC, Viollet B. Ampk activation Reduces hepatic Lipid content by increasing Fat oxidation in vivo. Int J Mol Sci. 2018;19(9). Epub 20180919. doi: https:\/\/doi.org\/10.3390\/ijms19092826.","DOI":"10.3390\/ijms19092826"},{"issue":"8","key":"7884_CR132","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1172\/JCI13505","volume":"108","author":"G Zhou","year":"2001","unstructured":"Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, et al. Role of amp-Activated protein kinase in mechanism of Metformin Action. J Clin Invest. 2001;108(8):1167\u201374. https:\/\/doi.org\/10.1172\/JCI13505.","journal-title":"J Clin Invest"},{"key":"7884_CR133","doi-asserted-by":"publisher","unstructured":"Taweesap P, Potue P, Khamseekaew J, Iampanichakul M, Jan OB, Pakdeechote P, et al. Luteolin relieves metabolic dysfunction-associated fatty Liver Disease Caused by a High-Fat Diet in Rats through modulating the Adipor1\/Ampk\/Ppargamma signaling pathway. Int J Mol Sci. 2025;26(8). Epub 20250417. doi: https:\/\/doi.org\/10.3390\/ijms26083804.","DOI":"10.3390\/ijms26083804"},{"issue":"4","key":"7884_CR134","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/ptr.3305","volume":"25","author":"JF Liu","year":"2011","unstructured":"Liu JF, Ma Y, Wang Y, Du ZY, Shen JK, Peng HL. Reduction of Lipid accumulation in Hepg2 cells by Luteolin is associated with activation of Ampk and mitigation of oxidative stress. Phytother Res. 2011;25(4):588\u201396. Epub 20101005. doi: https:\/\/doi.org\/10.1002\/ptr.3305.","journal-title":"Phytother Res"},{"issue":"20","key":"7884_CR135","doi-asserted-by":"publisher","first-page":"5618","DOI":"10.1021\/acs.jafc.1c01109","volume":"69","author":"YJ Zhou","year":"2021","unstructured":"Zhou YJ, Xu N, Zhang XC, Zhu YY, Liu SW, Chang YN. Chrysin Improves Glucose and Lipid metabolism disorders by Regulating the Ampk\/Pi3k\/Akt signaling pathway in insulin-Resistant Hepg2 cells and Hfd\/Stz-Induced C57bl\/6j Mice. J Agric Food Chem. 2021;69(20):5618\u201327. Epub 20210512. doi: https:\/\/doi.org\/10.1021\/acs.jafc.1c01109.","journal-title":"J Agric Food Chem"},{"issue":"3","key":"7884_CR136","first-page":"519","volume":"59","author":"S Kassovska-Bratinova","year":"1996","unstructured":"Kassovska-Bratinova S, Fukao T, Song XQ, Duncan AM, Chen HS, Robert MF, et al. Succinyl Coa: 3-Oxoacid Coa transferase (Scot): human cdna cloning, Human chromosomal mapping to 5p13, and mutation detection in a Scot-Deficient patient. Am J Hum Genet. 1996;59(3):519\u201328.","journal-title":"Am J Hum Genet"},{"issue":"5","key":"7884_CR137","doi-asserted-by":"publisher","first-page":"112336","DOI":"10.1016\/j.isci.2025.112336","volume":"28","author":"SA Tabatabaei Dakhili","year":"2025","unstructured":"Tabatabaei Dakhili SA, Yang K, Al Nebaihi H, Greenwell AA, Wuest M, Woodfield J, et al. Development of a Succinyl Coa: 3-ketoacid Coa transferase Inhibitor Selective for Peripheral tissues that Improves glycemia in Obesity. iScience. 2025;28(5):112336. Epub 20250403. doi: https:\/\/doi.org\/10.1016\/j.isci.2025.112336.","journal-title":"iScience"},{"key":"7884_CR138","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.biochi.2021.02.003","volume":"183","author":"SC Grunert","year":"2021","unstructured":"Grunert SC, Foster W, Schumann A, Lund A, Pontes C, Roloff S, et al. Succinyl-Coa: 3-Oxoacid coenzyme a transferase (Scot) deficiency: a rare and potentially fatal metabolic Disease. Biochimie. 2021;183:55\u201362. Epub 20210214. doi: https:\/\/doi.org\/10.1016\/j.biochi.2021.02.003.","journal-title":"Biochimie"},{"key":"7884_CR139","doi-asserted-by":"publisher","first-page":"747284","DOI":"10.3389\/fnut.2021.747284","volume":"8","author":"TY Lin","year":"2021","unstructured":"Lin TY, Liu HW, Hung TM. The Ketogenic Effect of Medium-chain triacylglycerides. Front Nutr. 2021;8:747284. Epub 20211118. doi: https:\/\/doi.org\/10.3389\/fnut.2021.747284.","journal-title":"Front Nutr"},{"issue":"6","key":"7884_CR140","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.cmet.2012.04.022","volume":"15","author":"C Canto","year":"2012","unstructured":"Canto C, Houtkooper RH, Pirinen E, Youn DY, Oosterveer MH, Cen Y, et al. The Nad(+) precursor Nicotinamide Riboside Enhances oxidative metabolism and Protects against High-Fat Diet-Induced Obesity. Cell Metab. 2012;15(6):838\u201347. https:\/\/doi.org\/10.1016\/j.cmet.2012.04.022.","journal-title":"Cell Metab"},{"key":"7884_CR141","doi-asserted-by":"publisher","unstructured":"Tabatabaei Dakhili SA, Yang K, Stenlund MJ, Ussher JR. The multifaceted roles of ketones in Physiology. Exp Physiol. 2025). Epub 20250511. doi: https:\/\/doi.org\/10.1113\/EP092243.","DOI":"10.1113\/EP092243"},{"key":"7884_CR142","doi-asserted-by":"publisher","unstructured":"Dilliraj LN, Schiuma G, Lara D, Strazzabosco G, Clement J, Giovannini P, et al. The Evolution of ketosis: potential Impact on clinical conditions. Nutrients. 2022;14(17). Epub 20220901. doi: https:\/\/doi.org\/10.3390\/nu14173613.","DOI":"10.3390\/nu14173613"},{"issue":"20","key":"7884_CR143","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1001\/jama.2022.14236","volume":"328","author":"R Marcus","year":"2022","unstructured":"Marcus R. What is Multiple Sclerosis? JAMA. 2022;328(20):2078. https:\/\/doi.org\/10.1001\/jama.2022.14236.","journal-title":"JAMA"},{"issue":"3","key":"7884_CR144","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/WCO.0000000000000206","volume":"28","author":"KSI Classification","year":"2015","unstructured":"Classification KSI. Diagnosis, and Differential Diagnosis of Multiple Sclerosis. Curr Opin Neurol. 2015;28(3):193\u2013205. https:\/\/doi.org\/10.1097\/WCO.0000000000000206.","journal-title":"Curr Opin Neurol"},{"issue":"11","key":"7884_CR145","doi-asserted-by":"publisher","first-page":"103449","DOI":"10.1016\/j.autrev.2023.103449","volume":"22","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wang J, Feng J. Multiple Sclerosis and pregnancy: pathogenesis, influencing factors, and Treatment options. Autoimmun Rev. 2023;22(11):103449. Epub 20230921. doi: https:\/\/doi.org\/10.1016\/j.autrev.2023.103449.","journal-title":"Autoimmun Rev"},{"issue":"10","key":"7884_CR146","first-page":"712","volume":"87","author":"R Nicholas","year":"2013","unstructured":"Nicholas R, Rashid W. Multiple Sclerosis. Am Fam Physician. 2013;87(10):712\u201314.","journal-title":"Am Fam Physician"},{"issue":"2","key":"7884_CR147","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1055\/s-0038-1649502","volume":"38","author":"BI Yamout","year":"2018","unstructured":"Yamout BI, Alroughani R. Multiple Sclerosis. Semin Neurol. 2018;38(2):212\u201325. Epub 20180523. doi: https:\/\/doi.org\/10.1055\/s-0038-1649502.","journal-title":"Semin Neurol"},{"key":"7884_CR148","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/B978-0-444-64076-5.00046-6","volume":"148","author":"C Cotsapas","year":"2018","unstructured":"Cotsapas C, Mitrovic M, Hafler D Multiple Sclerosis. Handb Clin Neurol. 2018;148:723\u201330. https:\/\/doi.org\/10.1016\/B978-0-444-64076-5.00046-6.","journal-title":"Handb Clin Neurol"},{"key":"7884_CR149","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.msard.2016.04.009","volume":"8","author":"JN Brenton","year":"2016","unstructured":"Brenton JN, Goldman MD. A Study of dietary modification: perceptions and attitudes of Patients with Multiple Sclerosis. Mult Scler Relat Disord. 2016;8:54\u201357. Epub 20160427. doi: https:\/\/doi.org\/10.1016\/j.msard.2016.04.009.","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"7884_CR150","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/S1474-4422(17)30408-8","volume":"17","author":"K Augustin","year":"2018","unstructured":"Augustin K, Khabbush A, Williams S, Eaton S, Orford M, Cross JH, et al. Mechanisms of Action for the Medium-chain triglyceride Ketogenic Diet in neurological and metabolic disorders. Lancet Neurol. 2018;17(1):84\u201393. Epub 20171216. doi: https:\/\/doi.org\/10.1016\/S1474-4422(17)30408-8.","journal-title":"Lancet Neurol"},{"issue":"10","key":"7884_CR151","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1111\/epi.18098","volume":"65","author":"X Tong","year":"2024","unstructured":"Tong X, Wang Q, Yang J, Zhou J, Chen X, Gan J, et al. Optimizing Ketogenic Diet Therapy for Childhood Epilepsy: identifying key factors for seizure Control and psychomotor enhancement. Epilepsia. 2024;65(10):2959\u201372. Epub 20240827. doi: https:\/\/doi.org\/10.1111\/epi.18098.","journal-title":"Epilepsia"},{"issue":"1","key":"7884_CR152","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/ana.24424","volume":"78","author":"DY Kim","year":"2015","unstructured":"Kim DY, Simeone KA, Simeone TA, Pandya JD, Wilke JC, Ahn Y, et al. Ketone bodies mediate antiseizure effects through mitochondrial permeability transition. Ann Neurol. 2015;78(1):77\u201387. Epub 20150506. doi: https:\/\/doi.org\/10.1002\/ana.24424.","journal-title":"Ann Neurol"},{"key":"7884_CR153","doi-asserted-by":"publisher","unstructured":"Pinto A, Bonucci A, Maggi E, Corsi M, Businaro R. Anti-oxidant and anti-inflammatory activity of Ketogenic Diet: new Perspectives for Neuroprotection in Alzheimer\u2019s Disease. Antioxid (Basel). 2018;7(5). Epub 20180428. doi: https:\/\/doi.org\/10.3390\/antiox7050063.","DOI":"10.3390\/antiox7050063"},{"issue":"4","key":"7884_CR154","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.molmed.2015.02.002","volume":"21","author":"S Offermanns","year":"2015","unstructured":"Offermanns S, Schwaninger M. Nutritional or pharmacological activation of Hca(2) Ameliorates Neuroinflammation. Trends Mol Med. 2015;21(4):245\u201355. Epub 20150309. doi: https:\/\/doi.org\/10.1016\/j.molmed.2015.02.002.","journal-title":"Trends Mol Med"},{"key":"7884_CR155","doi-asserted-by":"publisher","first-page":"106454","DOI":"10.1016\/j.eplepsyres.2020.106454","volume":"167","author":"S Koh","year":"2020","unstructured":"Koh S, Dupuis N, Auvin S Ketogenic Diet and Neuroinflammation. Epilepsy Res. 2020;167:106454. Epub 20200906. doi: https:\/\/doi.org\/10.1016\/j.eplepsyres.2020.106454.","journal-title":"Epilepsy Res"},{"key":"7884_CR156","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.msard.2018.02.019","volume":"22","author":"KC Fitzgerald","year":"2018","unstructured":"Fitzgerald KC, Tyry T, Salter A, Cofield SS, Cutter G, Fox RJ, et al. A survey of dietary Characteristics in a large Population of People with Multiple Sclerosis. Mult Scler Relat Disord. 2018;22:12\u201318. Epub 20180227. doi: https:\/\/doi.org\/10.1016\/j.msard.2018.02.019.","journal-title":"Mult Scler Relat Disord"},{"key":"7884_CR157","doi-asserted-by":"publisher","unstructured":"Brenton JN, Banwell B, Bergqvist AGC, Lehner-Gulotta D, Gampper L, Leytham E, et al. Pilot Study of a Ketogenic Diet in Relapsing-Remitting Ms. Neurol Neuroimmunol Neuroinflamm. 2019;6(4):e565. Epub 20190412. doi: https:\/\/doi.org\/10.1212\/NXI.0000000000000565.","DOI":"10.1212\/NXI.0000000000000565"},{"key":"7884_CR158","doi-asserted-by":"publisher","unstructured":"Wicks TR, Shalaurova I, Wolska A, Browne RW, Weinstock-Guttman B, Zivadinov R, et al. Endogenous ketone bodies are associated with metabolic vulnerability and disability in Multiple Sclerosis. Nutrients. 2025;17(4). Epub 20250211. doi: https:\/\/doi.org\/10.3390\/nu17040640.","DOI":"10.3390\/nu17040640"},{"key":"7884_CR159","doi-asserted-by":"publisher","unstructured":"Di Majo D, Cacciabaudo F, Accardi G, Gambino G, Giglia G, Ferraro G, et al. Ketogenic and modified Mediterranean Diet as a tool to counteract Neuroinflammation in Multiple Sclerosis: nutritional suggestions. Nutrients. 2022;14(12). Epub 20220608. doi: https:\/\/doi.org\/10.3390\/nu14122384.","DOI":"10.3390\/nu14122384"},{"issue":"3","key":"7884_CR160","doi-asserted-by":"publisher","first-page":"109225","DOI":"10.1016\/j.isci.2024.109225","volume":"27","author":"AE Oppong","year":"2024","unstructured":"Oppong AE, Coelewij L, Robertson G, Martin-Gutierrez L, Waddington KE, Donnes P, et al. Blood metabolomic and transcriptomic signatures stratify patient subgroups in Multiple Sclerosis according to Disease severity. iScience. 2024;27(3):109225. Epub 20240215. doi: https:\/\/doi.org\/10.1016\/j.isci.2024.109225.","journal-title":"iScience"},{"key":"7884_CR161","doi-asserted-by":"publisher","first-page":"101374","DOI":"10.1016\/j.msard.2019.08.016","volume":"36","author":"SB Claflin","year":"2019","unstructured":"Claflin SB, Tan B, Taylor BV. The Long-term effects of Disease modifying therapies on disability in People living with Multiple Sclerosis: a Systematic Review and Meta-Analysis. Mult Scler Relat Disord. 2019;36:101374. Epub 20190815. doi: https:\/\/doi.org\/10.1016\/j.msard.2019.08.016.","journal-title":"Mult Scler Relat Disord"},{"issue":"6","key":"7884_CR162","doi-asserted-by":"publisher","first-page":"102826","DOI":"10.1016\/j.autrev.2021.102826","volume":"20","author":"Z Liu","year":"2021","unstructured":"Liu Z, Liao Q, Wen H, Zhang Y. Disease modifying therapies in Relapsing-Remitting Multiple Sclerosis: a Systematic Review and Network Meta-Analysis. Autoimmun Rev. 2021;20(6):102826. Epub 20210418. doi: https:\/\/doi.org\/10.1016\/j.autrev.2021.102826.","journal-title":"Autoimmun Rev"},{"issue":"6","key":"7884_CR163","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1136\/jnnp-2022-329074","volume":"93","author":"JN Brenton","year":"2022","unstructured":"Brenton JN, Lehner-Gulotta D, Woolbright E, Banwell B, Bergqvist AGC, Chen S, et al. Phase Ii Study of Ketogenic diets in Relapsing Multiple Sclerosis: safety, Tolerability and potential clinical benefits. J Neurol Neurosurg Psychiatry. 2022;93(6):637\u201344. Epub 20220413. doi: https:\/\/doi.org\/10.1136\/jnnp-2022-329074.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"7884_CR164","doi-asserted-by":"publisher","first-page":"114891","DOI":"10.1016\/j.celrep.2024.114891","volume":"43","author":"M Alexander","year":"2024","unstructured":"Alexander M, Upadhyay V, Rock R, Ramirez L, Trepka K, Puchalska P, et al. A Diet-dependent host Metabolite shapes the gut microbiota to protect from autoimmunity. Cell Rep. 2024;43(11):114891. Epub 20241104. doi: https:\/\/doi.org\/10.1016\/j.celrep.2024.114891.","journal-title":"Cell Rep"},{"key":"7884_CR165","doi-asserted-by":"publisher","first-page":"1113954","DOI":"10.3389\/fneur.2023.1113954","volume":"14","author":"K Zyla-Jackson","year":"2023","unstructured":"Zyla-Jackson K, Walton DA, Plafker KS, Kovats S, Georgescu C, Brush RS, et al. Dietary Protection against the visual and motor deficits Induced by experimental autoimmune encephalomyelitis. Front Neurol. 2023;14:1113954. Epub 20230302. doi: https:\/\/doi.org\/10.3389\/fneur.2023.1113954.","journal-title":"Front Neurol"},{"key":"7884_CR166","doi-asserted-by":"publisher","unstructured":"Kakde SP, Qadeer A, Khalil M, Dhami A, Rashid Z, Zahir D, et al. Safety and efficacy of Ketogenic Diet in the management of Multiple Sclerosis: a Systematic Review. Cureus. 2025;17(8):e89965. Epub 20250813. doi: https:\/\/doi.org\/10.7759\/cureus.89965.","DOI":"10.7759\/cureus.89965"},{"issue":"2","key":"7884_CR167","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/path.1711650203","volume":"165","author":"AK Foulis","year":"1991","unstructured":"Foulis AK, McGill M, Farquharson MA. Insulitis in type 1 (insulin-dependent) Diabetes Mellitus in Man-macrophages, lymphocytes, and Interferon-Gamma containing cells. J Pathol. 1991;165(2):97\u2013103. https:\/\/doi.org\/10.1002\/path.1711650203.","journal-title":"J Pathol"},{"key":"7884_CR168","doi-asserted-by":"publisher","first-page":"914136","DOI":"10.3389\/fendo.2022.914136","volume":"13","author":"M Zhang","year":"2022","unstructured":"Zhang M, Zhou Y, Xie Z, Luo S, Zhou Z, Huang J, et al. New developments in T Cell immunometabolism and therapeutic Implications for type 1 Diabetes. Front Endocrinol (Lausanne). 2022;13:914136. Epub 20220610. doi: https:\/\/doi.org\/10.3389\/fendo.2022.914136.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"7884_CR169","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41392-024-01954-6","volume":"9","author":"T Hu","year":"2024","unstructured":"Hu T, Liu CH, Lei M, Zeng Q, Li L, Tang H, et al. Metabolic regulation of the immune System in Health and diseases: mechanisms and interventions. Signal Transduct Target Ther. 2024;9(1):268. Epub 20241009. doi: https:\/\/doi.org\/10.1038\/s41392-024-01954-6.","journal-title":"Signal Transduct Target Ther"},{"issue":"6116","key":"7884_CR170","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1126\/science.1227166","volume":"339","author":"T Shimazu","year":"2013","unstructured":"Shimazu T, Hirschey MD, Newman J, He W, Shirakawa K, Le Moan N, et al. Suppression of oxidative stress by Beta-Hydroxybutyrate, an endogenous Histone Deacetylase Inhibitor. Science. 2013;339(6116):211\u201314. Epub 20121206. doi: https:\/\/doi.org\/10.1126\/science.1227166.","journal-title":"Science"},{"key":"7884_CR171","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.freeradbiomed.2016.03.020","volume":"95","author":"P Kanikarla-Marie","year":"2016","unstructured":"Kanikarla-Marie P, Jain SK. Hyperketonemia and ketosis increase the risk of Complications in type 1 Diabetes. Free Radic Biol Med. 2016;95:268\u201377. Epub 20160329. doi: https:\/\/doi.org\/10.1016\/j.freeradbiomed.2016.03.020.","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"7884_CR172","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1089\/dia.2018.0356","volume":"21","author":"S Siebel","year":"2019","unstructured":"Siebel S, Galderisi A, Patel NS, Carria LR, Tamborlane WV, Sherr JL. Reversal of ketosis in type 1 Diabetes is not adversely affected by Sglt2 Inhibitor Therapy. Diabetes Technol Ther. 2019;21(3):101\u201304. Epub 20190128. doi: https:\/\/doi.org\/10.1089\/dia.2018.0356.","journal-title":"Diabetes Technol Ther"},{"issue":"5","key":"7884_CR173","doi-asserted-by":"publisher","first-page":"98","DOI":"10.31083\/j.fbl2805098","volume":"28","author":"Y Ma","year":"2023","unstructured":"Ma Y, Zhao Q, Peng H, Nalisa DL, Shan P, Jiang H. Sglt2i in Patients with type 1 Diabetes: benefits, Risks, and preventive strategies. Front Biosci (Landmark Ed). 2023;28(5):98. https:\/\/doi.org\/10.31083\/j.fbl2805098.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"7884_CR174","doi-asserted-by":"publisher","unstructured":"Elian V, Popovici V, Karampelas O, Pircalabioru GG, Radulian G, Musat M. Risks and benefits of Sglt-2 inhibitors for type 1 Diabetes Patients Using automated insulin delivery Systems-a literature Review. Int J Mol Sci. 2024;25(4). Epub 20240206. doi: https:\/\/doi.org\/10.3390\/ijms25041972.","DOI":"10.3390\/ijms25041972"},{"key":"7884_CR175","doi-asserted-by":"publisher","first-page":"44128","DOI":"10.1038\/srep44128","volume":"7","author":"J Chen","year":"2017","unstructured":"Chen J, Fan F, Wang JY, Long Y, Gao CL, Stanton RC, et al. The efficacy and safety of Sglt2 inhibitors for adjunctive Treatment of type 1 Diabetes: a Systematic Review and Meta-Analysis. Sci Rep. 2017;7:44128. Epub 20170309. doi: https:\/\/doi.org\/10.1038\/srep44128.","journal-title":"Sci Rep"},{"key":"7884_CR176","doi-asserted-by":"publisher","unstructured":"Yoo BM, Kim SR, Lee BW. Ketone body induction: insights into metabolic Disease management. Biomedicines. 2025;13(6). Epub 20250616. doi: https:\/\/doi.org\/10.3390\/biomedicines13061484.","DOI":"10.3390\/biomedicines13061484"},{"key":"7884_CR177","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/art.1780050610","volume":"5","author":"JE Seegmiller","year":"1962","unstructured":"Seegmiller JE, Howell RR. The Old and New concepts of Acute gouty Arthritis. Arthritis Rheum. 1962;5:616\u201323. https:\/\/doi.org\/10.1002\/art.1780050610.","journal-title":"Arthritis Rheum"},{"key":"7884_CR178","doi-asserted-by":"publisher","unstructured":"Remund NP, Larsen JG, Shin MJ, Warren CE, Palmer IL, Kim IJ, et al. The role of Beta-Hydroxybutyrate in mitigating the inflammatory and metabolic consequences of Uric acid. Metabolites. 2024;14(12). Epub 20241204. doi: https:\/\/doi.org\/10.3390\/metabo14120679.","DOI":"10.3390\/metabo14120679"},{"issue":"7081","key":"7884_CR179","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"F Martinon","year":"2006","unstructured":"Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated Uric acid crystals activate the Nalp3 inflammasome. Nature. 2006;440(7081):237\u201341. Epub 20060111. doi: https:\/\/doi.org\/10.1038\/nature04516.","journal-title":"Nature"},{"key":"7884_CR180","doi-asserted-by":"publisher","unstructured":"Athinarayanan SJ, Roberts CGP, Vangala C, Shetty GK, McKenzie AL, Weimbs T, et al. The Case for a Ketogenic Diet in the management of Kidney Disease. BMJ Open Diabetes Res Care. 2024;12(2). Epub 20240427. doi: https:\/\/doi.org\/10.1136\/bmjdrc-2024-004101.","DOI":"10.1136\/bmjdrc-2024-004101"},{"issue":"1","key":"7884_CR181","doi-asserted-by":"publisher","first-page":"10492","DOI":"10.1038\/s41598-023-37672-2","volume":"13","author":"S Gohari","year":"2023","unstructured":"Gohari S, Ghobadi S, Jafari A, Ahangar H, Gohari S, Mahjani M. The Effect of dietary approaches to stop hypertension and Ketogenic diets intervention on Serum Uric acid Concentration: a Systematic Review and Meta-Analysis of Randomized controlled trials. Sci Rep. 2023;13(1):10492. Epub 20230628. doi: https:\/\/doi.org\/10.1038\/s41598-023-37672-2.","journal-title":"Sci Rep"},{"key":"7884_CR182","doi-asserted-by":"publisher","first-page":"1538266","DOI":"10.3389\/fnut.2025.1538266","volume":"12","author":"O Skartun","year":"2025","unstructured":"Skartun O, Smith CR, Laupsa-Borge J, Dankel SN. Symptoms during Initiation of a Ketogenic Diet: a scoping Review of occurrence rates, mechanisms and relief strategies. Front Nutr. 2025;12:1538266. Epub 20250326. doi: https:\/\/doi.org\/10.3389\/fnut.2025.1538266.","journal-title":"Front Nutr"},{"key":"7884_CR183","doi-asserted-by":"publisher","unstructured":"Acharya P, Acharya C, Thongprayoon C, Hansrivijit P, Kanduri SR, Kovvuru K, et al. Incidence and Characteristics of Kidney stones in Patients on Ketogenic Diet: a Systematic Review and Meta-Analysis. Diseases. 2021;9(2). Epub 20210525. doi: https:\/\/doi.org\/10.3390\/diseases9020039.","DOI":"10.3390\/diseases9020039"},{"key":"7884_CR184","doi-asserted-by":"publisher","unstructured":"Joshi S, Shi R, Patel J. Risks of the Ketogenic Diet in Ckd - the con part. Clin Kidney J. 2024;17(1):sfad274. Epub 20231107. doi: https:\/\/doi.org\/10.1093\/ckj\/sfad274.","DOI":"10.1093\/ckj\/sfad274"},{"issue":"7152","key":"7884_CR185","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/nature06005","volume":"448","author":"RJ Xavier","year":"2007","unstructured":"Xavier RJ, Podolsky DK. Unravelling the Pathogenesis of inflammatory bowel Disease. Nature. 2007;448(7152):427\u201334. https:\/\/doi.org\/10.1038\/nature06005.","journal-title":"Nature"},{"key":"7884_CR186","doi-asserted-by":"publisher","first-page":"104892","DOI":"10.1016\/j.phrs.2020.104892","volume":"159","author":"V Annese","year":"2020","unstructured":"Annese V. Genetics and Epigenetics of Ibd. Pharmacol Res. 2020;159:104892. Epub 20200525. doi: https:\/\/doi.org\/10.1016\/j.phrs.2020.104892.","journal-title":"Pharmacol Res"},{"issue":"1","key":"7884_CR187","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41575-020-00360-x","volume":"18","author":"GG Kaplan","year":"2021","unstructured":"Kaplan GG, Windsor JW. The four epidemiological stages in the Global Evolution of inflammatory bowel Disease. Nat Rev Gastroenterol Hepatol. 2021;18(1):56\u201366. Epub 20201008. doi: https:\/\/doi.org\/10.1038\/s41575-020-00360-x.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"7884_CR188","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/cmi.2014.15","volume":"11","author":"Y Lin","year":"2014","unstructured":"Lin Y, Yang X, Yue W, Xu X, Li B, Zou L, et al. Chemerin aggravates dss-Induced Colitis by Suppressing M2 Macrophage polarization. Cell Mol Immunol. 2014;11(4):355\u201366. Epub 20140414. doi: https:\/\/doi.org\/10.1038\/cmi.2014.15.","journal-title":"Cell Mol Immunol"},{"key":"7884_CR189","doi-asserted-by":"publisher","first-page":"1541414","DOI":"10.3389\/fpsyt.2025.1541414","volume":"16","author":"L Calabrese","year":"2025","unstructured":"Calabrese L. Remission of Ocd and Ulcerative Colitis with a Ketogenic Diet: case report. Front Psychiatry. 2025;16:1541414. Epub 20250403. doi: https:\/\/doi.org\/10.3389\/fpsyt.2025.1541414.","journal-title":"Front Psychiatry"},{"issue":"2","key":"7884_CR190","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1006\/bbrc.1996.1039","volume":"224","author":"KM Tytgat","year":"1996","unstructured":"Tytgat KM, van der Wal JW, Einerhand AW, Buller HA, Dekker J. Quantitative Analysis of Muc2 Synthesis in Ulcerative Colitis. Biochem Biophys Res Commun. 1996;224(2):397\u2013405. https:\/\/doi.org\/10.1006\/bbrc.1996.1039.","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"7884_CR191","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1136\/gutjnl-2018-317571","volume":"68","author":"S van der Post","year":"2019","unstructured":"van der Post S, Jabbar KS, Birchenough G, Arike L, Akhtar N, Sjovall H, et al. Structural weakening of the colonic mucus barrier is an early event in Ulcerative Colitis Pathogenesis. Gut. 2019;68(12):2142\u201351. Epub 20190326. doi: https:\/\/doi.org\/10.1136\/gutjnl-2018-317571.","journal-title":"Gut"},{"key":"7884_CR192","doi-asserted-by":"publisher","unstructured":"Bankole E, Read E, Curtis MA, Neves JF, Garnett JA. The relationship between Mucins and Ulcerative Colitis: a Systematic Review. J Clin Med. 2021;10(9). Epub 20210430. doi: https:\/\/doi.org\/10.3390\/jcm10091935.","DOI":"10.3390\/jcm10091935"},{"key":"7884_CR193","doi-asserted-by":"publisher","first-page":"112729","DOI":"10.1016\/j.intimp.2024.112729","volume":"140","author":"X Zeng","year":"2024","unstructured":"Zeng X, Hu Y, Qiao S, Cao X, Dai Y, Wu F, et al. Adora3 activation promotes goblet Cell differentiation via enhancing Hmgcs2-mediated ketogenesis in Ulcerative Colitis. Int Immunopharmacol. 2024;140:112729. Epub 20240803. doi: https:\/\/doi.org\/10.1016\/j.intimp.2024.112729.","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"7884_CR194","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.cell.2020.04.027","volume":"181","author":"QY Ang","year":"2020","unstructured":"Ang QY, Alexander M, Newman JC, Tian Y, Cai J, Upadhyay V, et al. Ketogenic diets alter the gut microbiome resulting in decreased intestinal Th17 cells. Cell. 2020;181(6):1263\u201375 e16. Epub 20200520. doi: https:\/\/doi.org\/10.1016\/j.cell.2020.04.027.","journal-title":"Cell"},{"issue":"1","key":"7884_CR195","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41392-021-00549-9","volume":"6","author":"C Kong","year":"2021","unstructured":"Kong C, Yan X, Liu Y, Huang L, Zhu Y, He J, et al. Ketogenic Diet alleviates Colitis by Reduction of colonic group 3 innate lymphoid cells through altering gut microbiome. Signal Transduct Target Ther. 2021;6(1):154. Epub 20210423. doi: https:\/\/doi.org\/10.1038\/s41392-021-00549-9.","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"7884_CR196","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety delphi consensus statement on New fatty Liver Disease nomenclature. Hepatology. 2023;78(6):1966\u201386. Epub 20230624. doi: https:\/\/doi.org\/10.1097\/HEP.0000000000000520.","journal-title":"Hepatology"},{"issue":"1","key":"7884_CR197","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of Nonalcoholic fatty Liver Disease-Meta-analytic assessment of Prevalence, incidence, and Outcomes. Hepatology. 2016;64(1):73\u201384. Epub 20160222. doi: https:\/\/doi.org\/10.1002\/hep.28431.","journal-title":"Hepatology"},{"issue":"1","key":"7884_CR198","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","volume":"8","author":"J Quek","year":"2023","unstructured":"Quek J, Chan KE, Wong ZY, Tan C, Tan B, Lim WH, et al. Global Prevalence of Non-Alcoholic fatty Liver Disease and Non-Alcoholic Steatohepatitis in the overweight and Obese Population: A Systematic Review and Meta-Analysis. Lancet Gastroenterol Hepatol. 2023;8(1):20\u201330. Epub 20221116. doi: https:\/\/doi.org\/10.1016\/S2468-1253(22)00317-X.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"10290","key":"7884_CR199","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell EE, Wong VW, Rinella M. Non-Alcoholic fatty Liver Disease. Lancet. 2021;397(10290):2212\u201324. Epub 20210421. doi: https:\/\/doi.org\/10.1016\/S0140-6736(20)32511-3.","journal-title":"Lancet"},{"issue":"7","key":"7884_CR200","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1113\/JP283820","volume":"601","author":"P Subramanian","year":"2023","unstructured":"Subramanian P, Chavakis T. The complex function of macrophages and their subpopulations in metabolic injury associated fatty Liver Disease. J Physiol. 2023;601(7):1159\u201371. Epub 20230311. doi: https:\/\/doi.org\/10.1113\/JP283820.","journal-title":"J Physiol"},{"issue":"4","key":"7884_CR201","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1002\/hep.32336","volume":"75","author":"P Ramadori","year":"2022","unstructured":"Ramadori P, Kam S, Heikenwalder M. T cells: friends and foes in Nash Pathogenesis and Hepatocarcinogenesis. Hepatology. 2022;75(4):1038\u201349. Epub 20220204. doi: https:\/\/doi.org\/10.1002\/hep.32336.","journal-title":"Hepatology"},{"key":"7884_CR202","doi-asserted-by":"publisher","unstructured":"Garbow JR, Doherty JM, Schugar RC, Travers S, Weber ML, Wentz AE, et al. Hepatic Steatosis, inflammation, and Er stress in Mice maintained Long term on a Very Low-Carbohydrate Ketogenic Diet. Am J Physiol Gastrointest Liver Physiol. 2011;300(6):G956\u201367. Epub 20110331. doi: https:\/\/doi.org\/10.1152\/ajpgi.00539.2010.","DOI":"10.1152\/ajpgi.00539.2010"},{"key":"7884_CR203","doi-asserted-by":"publisher","unstructured":"Holm S, Husted AS, Skov LJ, Morville TH, Hagemann CA, Jorsal T, et al. Beta-Hydroxybutyrate Suppresses hepatic production of the ghrelin receptor antagonist Leap2. Endocrinology. 2022;163(6). https:\/\/doi.org\/10.1210\/endocr\/bqac038.","DOI":"10.1210\/endocr\/bqac038"},{"issue":"21","key":"7884_CR204","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1161\/CIRCULATIONAHA.124.069217","volume":"149","author":"AF Hernandez","year":"2024","unstructured":"Hernandez AF, Udell JA, Jones WS, Anker SD, Petrie MC, Harrington J, et al. Effect of Empagliflozin on Heart failure Outcomes after Acute Myocardial Infarction: insights from the Empact-Mi Trial. Circulation. 2024;149(21):1627\u201338. Epub 20240406. doi: https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.124.069217.","journal-title":"Circulation"},{"issue":"15","key":"7884_CR205","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","volume":"383","author":"M Packer","year":"2020","unstructured":"Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P, et al. Cardiovascular and renal Outcomes with Empagliflozin in Heart failure. N Engl J Med. 2020;383(15):1413\u201324. Epub 20200828. doi: https:\/\/doi.org\/10.1056\/NEJMoa2022190.","journal-title":"N Engl J Med"},{"key":"7884_CR206","doi-asserted-by":"publisher","unstructured":"Mghaieth Zghal F, Abbassi M, Silini A, Ben Halima M, Jebberi Z, Daly F, et al. Impact of Sodium-Glucose Cotransporter inhibitors in Acute coronary Syndrome Patients on Endothelial function and Atherosclerosis Related-biomarkers: ath-Sglt2i Pilot Study. Med (Baltim). 2024;103(47):e40536. https:\/\/doi.org\/10.1097\/MD.0000000000040536.","DOI":"10.1097\/MD.0000000000040536"},{"key":"7884_CR207","doi-asserted-by":"publisher","unstructured":"King A, Tan X, Dhopeshwarkar N, Bohn R, Dea K, Leonard CE, et al. Recent Trends in glp-1 Ra and Sglt2i use among People with type 2 Diabetes and atherosclerotic Cardiovascular Disease in the USA. BMJ Open Diabetes Res Care. 2024;12(5). Epub 20241004. doi: https:\/\/doi.org\/10.1136\/bmjdrc-2024-004431.","DOI":"10.1136\/bmjdrc-2024-004431"},{"issue":"4","key":"7884_CR208","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.hfc.2022.03.007","volume":"18","author":"AJ Nelson","year":"2022","unstructured":"Nelson AJ, Harrington JL, Kolkailah AA, Pagidipati NJ, McGuire DK. Sodium-Glucose Cotransporter-2 inhibitors: impact on Atherosclerosis and atherosclerotic Cardiovascular Disease Events. Heart Fail Clin. 2022;18(4):597\u2013607. https:\/\/doi.org\/10.1016\/j.hfc.2022.03.007.","journal-title":"Heart Fail Clin"},{"issue":"12","key":"7884_CR209","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1042\/BCJ20200278","volume":"477","author":"EA Day","year":"2020","unstructured":"Day EA, Ford RJ, Lu JH, Lu R, Lundenberg L, Desjardins EM, et al. The Sglt2 Inhibitor Canagliflozin Suppresses Lipid Synthesis and interleukin-1 Beta in Apoe Deficient Mice. Biochem J. 2020;477(12):2347\u201361. https:\/\/doi.org\/10.1042\/BCJ20200278.","journal-title":"Biochem J"},{"key":"7884_CR210","doi-asserted-by":"publisher","unstructured":"Nakatsu Y, Kokubo H, Bumdelger B, Yoshizumi M, Yamamotoya T, Matsunaga Y, et al. The Sglt2 Inhibitor Luseogliflozin Rapidly normalizes Aortic mrna levels of inflammation-Related but not Lipid-metabolism-Related Genes and Suppresses Atherosclerosis in Diabetic Apoe Ko Mice. Int J Mol Sci. 2017;18(8). Epub 20170804. doi: https:\/\/doi.org\/10.3390\/ijms18081704.","DOI":"10.3390\/ijms18081704"},{"issue":"1","key":"7884_CR211","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12933-019-0947-5","volume":"18","author":"Y Mori","year":"2019","unstructured":"Mori Y, Terasaki M, Hiromura M, Saito T, Kushima H, Koshibu M, et al. Luseogliflozin Attenuates Neointimal Hyperplasia after wire injury in High-Fat Diet-Fed Mice via inhibition of perivascular Adipose tissue Remodeling. Cardiovasc Diabetol. 2019;18(1):143. Epub 20191031. doi: https:\/\/doi.org\/10.1186\/s12933-019-0947-5.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"7884_CR212","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12933-019-0886-1","volume":"18","author":"K Mori","year":"2019","unstructured":"Mori K, Tsuchiya K, Nakamura S, Miyachi Y, Shiba K, Ogawa Y, et al. Ipragliflozin-Induced Adipose Expansion inhibits cuff-Induced vascular Remodeling in Mice. Cardiovasc Diabetol. 2019;18(1):83. Epub 20190624. doi: https:\/\/doi.org\/10.1186\/s12933-019-0886-1.","journal-title":"Cardiovasc Diabetol"},{"key":"7884_CR213","doi-asserted-by":"publisher","first-page":"6305735","DOI":"10.1155\/2016\/6305735","volume":"2016","author":"W Leng","year":"2016","unstructured":"Leng W, Ouyang X, Lei X, Wu M, Chen L, Wu Q, et al. The Sglt-2 Inhibitor Dapagliflozin has a therapeutic Effect on Atherosclerosis in Diabetic Apoe(-\/-) Mice. Mediators Inflamm. 2016;2016:6305735. Epub 20161226. doi: https:\/\/doi.org\/10.1155\/2016\/6305735.","journal-title":"Mediators Inflamm"},{"key":"7884_CR214","doi-asserted-by":"publisher","unstructured":"Terasaki M, Hiromura M, Mori Y, Kohashi K, Nagashima M, Kushima H, et al. Amelioration of Hyperglycemia with a Sodium-Glucose Cotransporter 2 Inhibitor prevents Macrophage-driven Atherosclerosis through Macrophage foam Cell formation Suppression in type 1 and type 2 Diabetic Mice. PLoS One. 2015;10(11):e0143396. Epub 20151125. doi: https:\/\/doi.org\/10.1371\/journal.pone.0143396.","DOI":"10.1371\/journal.pone.0143396"},{"issue":"1","key":"7884_CR215","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12933-018-0749-1","volume":"17","author":"N Nasiri-Ansari","year":"2018","unstructured":"Nasiri-Ansari N, Dimitriadis GK, Agrogiannis G, Perrea D, Kostakis ID, Kaltsas G, et al. Canagliflozin Attenuates the progression of Atherosclerosis and inflammation process in Apoe Knockout Mice. Cardiovasc Diabetol. 2018;17(1):106. Epub 20180726. doi: https:\/\/doi.org\/10.1186\/s12933-018-0749-1.","journal-title":"Cardiovasc Diabetol"},{"issue":"9","key":"7884_CR216","doi-asserted-by":"publisher","first-page":"4502","DOI":"10.7150\/thno.54498","volume":"11","author":"Z Liu","year":"2021","unstructured":"Liu Z, Ma X, Ilyas I, Zheng X, Luo S, Little PJ, et al. Impact of Sodium Glucose Cotransporter 2 (Sglt2) inhibitors on Atherosclerosis: from pharmacology to pre-clinical and clinical Therapeutics. Theranostics. 2021;11(9):4502\u201315. Epub 20210304. doi: https:\/\/doi.org\/10.7150\/thno.54498.","journal-title":"Theranostics"},{"issue":"6","key":"7884_CR217","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.diabet.2018.09.005","volume":"44","author":"F Bonnet","year":"2018","unstructured":"Bonnet F, Scheen AJ. Effects of Sglt2 inhibitors on systemic and tissue Low-grade inflammation: the potential contribution to Diabetes Complications and Cardiovascular Disease. Diabetes Metab. 2018;44(6):457\u201364. Epub 20180926. doi: https:\/\/doi.org\/10.1016\/j.diabet.2018.09.005.","journal-title":"Diabetes Metab"},{"issue":"1","key":"7884_CR218","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1038\/s41467-020-15983-6","volume":"11","author":"SR Kim","year":"2020","unstructured":"Kim SR, Lee SG, Kim SH, Kim JH, Choi E, Cho W, et al. Sglt2 inhibition Modulates Nlrp3 inflammasome activity via ketones and insulin in Diabetes with Cardiovascular Disease. Nat Commun. 2020;11(1):2127. Epub 20200501. doi: https:\/\/doi.org\/10.1038\/s41467-020-15983-6.","journal-title":"Nat Commun"},{"key":"7884_CR219","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3389\/fphys.2017.01077","volume":"8","author":"I Andreadou","year":"2017","unstructured":"Andreadou I, Efentakis P, Balafas E, Togliatto G, Davos CH, Varela A, et al. Empagliflozin limits Myocardial Infarction in vivo and Cell death in vitro: role of Stat3, mitochondria, and Redox aspects. Front Physiol. 2017;8:1077. Epub 20171219. doi: https:\/\/doi.org\/10.3389\/fphys.2017.01077.","journal-title":"Front Physiol"},{"issue":"7","key":"7884_CR220","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1089\/ars.2019.7923","volume":"34","author":"PE Nikolaou","year":"2021","unstructured":"Nikolaou PE, Efentakis P, Abu Qourah F, Femmino S, Makridakis M, Kanaki Z, et al. Chronic Empagliflozin Treatment Reduces Myocardial infarct size in Nondiabetic Mice through stat-3-mediated Protection on microvascular Endothelial cells and Reduction of oxidative stress. Antioxid Redox Signal. 2021;34(7):551\u201371. Epub 20210127. doi: https:\/\/doi.org\/10.1089\/ars.2019.7923.","journal-title":"Antioxid Redox Signal"},{"key":"7884_CR221","doi-asserted-by":"publisher","unstructured":"Nikolaou PE, Konijnenberg LSF, Kostopoulos M IV, Mylonas M, Georgoulis N, A, et al. Empagliflozin in Acute Myocardial Infarction Reduces No-reflow and preserves Cardiac function by preventing Endothelial damage. JACC Basic Transl Sci. 2025;10(1):43\u201361. Epub 20240830. doi: https:\/\/doi.org\/10.1016\/j.jacbts.2024.08.003.","DOI":"10.1016\/j.jacbts.2024.08.003"},{"issue":"1","key":"7884_CR222","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12944-021-01430-y","volume":"20","author":"Y Liu","year":"2021","unstructured":"Liu Y, Xu J, Wu M, Xu B, Kang L. Empagliflozin Protects against Atherosclerosis progression by modulating Lipid profiles and sympathetic activity. Lipids Health Dis. 2021;20(1):5. Epub 20210112. doi: https:\/\/doi.org\/10.1186\/s12944-021-01430-y.","journal-title":"Lipids Health Dis"},{"issue":"5","key":"7884_CR223","doi-asserted-by":"publisher","first-page":"443","DOI":"10.4070\/kcj.2019.0296","volume":"50","author":"SG Lee","year":"2020","unstructured":"Lee SG, Lee SJ, Lee JJ, Kim JS, Lee OH, Kim CK, et al. Anti-inflammatory Effect for Atherosclerosis progression by Sodium-Glucose Cotransporter 2 (Sglt-2) Inhibitor in a normoglycemic rabbit model. Korean Circ J. 2020;50(5):443\u201357. Epub 20200212. doi: https:\/\/doi.org\/10.4070\/kcj.2019.0296.","journal-title":"Korean Circ J"},{"issue":"3","key":"7884_CR224","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.cmet.2020.06.020","volume":"32","author":"I Tomita","year":"2020","unstructured":"Tomita I, Kume S, Sugahara S, Osawa N, Yamahara K, Yasuda-Yamahara M, et al. Sglt2 inhibition Mediates Protection from Diabetic Kidney Disease by promoting ketone body-Induced Mtorc1 inhibition. Cell Metab. 2020;32(3):404\u201319 e6. Epub 20200728. doi: https:\/\/doi.org\/10.1016\/j.cmet.2020.06.020.","journal-title":"Cell Metab"},{"issue":"1","key":"7884_CR225","doi-asserted-by":"publisher","first-page":"17937","DOI":"10.1038\/s41598-019-54224-9","volume":"9","author":"J Pennig","year":"2019","unstructured":"Pennig J, Scherrer P, Gissler MC, Anto-Michel N, Hoppe N, Funer L, et al. Glucose lowering by Sglt2-Inhibitor Empagliflozin accelerates Atherosclerosis regression in hyperglycemic Stz-Diabetic Mice. Sci Rep. 2019;9(1):17937. Epub 20191129. doi: https:\/\/doi.org\/10.1038\/s41598-019-54224-9.","journal-title":"Sci Rep"},{"issue":"8","key":"7884_CR226","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1161\/ATVBAHA.119.312659","volume":"39","author":"R Ortega","year":"2019","unstructured":"Ortega R, Collado A, Selles F, Gonzalez-Navarro H, Sanz MJ, Real JT, et al. Sglt-2 (Sodium-Glucose Cotransporter 2) inhibition Reduces Ang Ii (angiotensin Ii)-Induced dissecting abdominal Aortic aneurysm in Apoe (apolipoprotein E) Knockout Mice. Arterioscler Thromb Vasc Biol. 2019;39(8):1614\u201328. Epub 20190711. doi: https:\/\/doi.org\/10.1161\/ATVBAHA.119.312659.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7884_CR227","doi-asserted-by":"publisher","unstructured":"Arnott C, Li Q, Kang A, Neuen BL, Bompoint S, Lam CSP, et al. Sodium-Glucose Cotransporter 2 inhibition for the Prevention of Cardiovascular Events in Patients with type 2 Diabetes Mellitus: a Systematic Review and Meta-Analysis. J Am Heart Assoc. 2020;9(3):e014908. Epub 20200129. doi: https:\/\/doi.org\/10.1161\/JAHA.119.014908.","DOI":"10.1161\/JAHA.119.014908"},{"issue":"1","key":"7884_CR228","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12933-019-0916-z","volume":"18","author":"Y Fei","year":"2019","unstructured":"Fei Y, Tsoi MF, Cheung BMY. Cardiovascular Outcomes in trials of New antidiabetic Drug classes: a Network Meta-Analysis. Cardiovasc Diabetol. 2019;18(1):112. Epub 20190828. doi: https:\/\/doi.org\/10.1186\/s12933-019-0916-z.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"7884_CR229","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12933-024-02150-0","volume":"23","author":"PT Htoo","year":"2024","unstructured":"Htoo PT, Tesfaye H, Schneeweiss S, Wexler DJ, Everett BM, Glynn RJ, et al. Cardiorenal effectiveness of Empagliflozin vs. Glucagon-like peptide-1 receptor agonists: final-year results from the emprise Study. Cardiovasc Diabetol. 2024;23(1):57. Epub 20240208. doi: https:\/\/doi.org\/10.1186\/s12933-024-02150-0.","journal-title":"Cardiovasc Diabetol"},{"key":"7884_CR230","doi-asserted-by":"publisher","first-page":"792846","DOI":"10.3389\/fmed.2021.792846","volume":"8","author":"J Ciaffi","year":"2021","unstructured":"Ciaffi J, Mitselman D, Mancarella L, Brusi V, Lisi L, Ruscitti P, et al. The Effect of Ketogenic Diet on inflammatory Arthritis and Cardiovascular Health in rheumatic conditions: a mini Review. Front Med (Lausanne). 2021;8:792846. Epub 20211214. doi: https:\/\/doi.org\/10.3389\/fmed.2021.792846.","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"7884_CR231","doi-asserted-by":"publisher","first-page":"75","DOI":"10.12788\/cutis.0942","volume":"113","author":"K Roster","year":"2024","unstructured":"Roster K, Xie L, Nguyen T, Lipner SR. Impact of Ketogenic and Low-glycemic diets on inflammatory skin conditions. Cutis. 2024;113(2):75\u201380. https:\/\/doi.org\/10.12788\/cutis.0942.","journal-title":"Cutis"},{"issue":"2","key":"7884_CR232","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1080\/10408398.2020.1818053","volume":"62","author":"L Barrea","year":"2022","unstructured":"Barrea L, Megna M, Cacciapuoti S, Frias-Toral E, Fabbrocini G, Savastano S, et al. Very Low-Calorie Ketogenic Diet (vlckd) in Patients with Psoriasis and Obesity: an Update for dermatologists and nutritionists. Crit Rev Food Sci Nutr. 2022;62(2):398\u2013414. Epub 20200924. doi: https:\/\/doi.org\/10.1080\/10408398.2020.1818053.","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"1","key":"7884_CR233","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12974-020-01948-5","volume":"17","author":"DC Shippy","year":"2020","unstructured":"Shippy DC, Wilhelm C, Viharkumar PA, Raife TJ, Ulland TK. Beta-Hydroxybutyrate inhibits inflammasome activation to attenuate Alzheimer\u2019s Disease pathology. J Neuroinflammation. 2020;17(1):280. Epub 20200921. doi: https:\/\/doi.org\/10.1186\/s12974-020-01948-5.","journal-title":"J Neuroinflammation"},{"key":"7884_CR234","doi-asserted-by":"publisher","unstructured":"Jin LW, Di Lucente J, Ruiz Mendiola U, Suthprasertporn N, Tomilov A, Cortopassi G, et al. The ketone body Beta-Hydroxybutyrate shifts microglial metabolism and Suppresses amyloid-Beta oligomer-Induced inflammation in Human microglia. Faseb J. 2023;37(11):e23261. https:\/\/doi.org\/10.1096\/fj.202301254R.","DOI":"10.1096\/fj.202301254R"},{"key":"7884_CR235","doi-asserted-by":"publisher","unstructured":"Vranjic P, Vukovic M, Blazetic S, Viljetic B. Ketogenic Diet and thyroid function: a delicate metabolic balancing act. Curr Issues Mol Biol. 2025;47(9). Epub 20250828. doi: https:\/\/doi.org\/10.3390\/cimb47090696.","DOI":"10.3390\/cimb47090696"},{"issue":"1","key":"7884_CR236","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12902-021-00922-3","volume":"22","author":"A Charoenpiriya","year":"2022","unstructured":"Charoenpiriya A, Chailurkit L, Ongphiphadhanakul B. Comparisons of biochemical parameters and Diabetic ketoacidosis severity in Adult Patients with type 1 and type 2 Diabetes. BMC Endocr Disord. 2022;22(1):7. Epub 20220106. doi: https:\/\/doi.org\/10.1186\/s12902-021-00922-3.","journal-title":"BMC Endocr Disord"},{"issue":"2","key":"7884_CR237","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/j.1423-0410.1993.tb02531.x","volume":"64","author":"MS Chadha","year":"1993","unstructured":"Chadha MS, Arankalle VA, Jha J, Banerjee K. Prevalence of hepatitis B and C virus Infections among haemodialysis Patients in Pune (Western India). Vox Sang. 1993;64(2):127\u201328. https:\/\/doi.org\/10.1111\/j.1423-0410.1993.tb02531.x.","journal-title":"Vox Sang"},{"issue":"5","key":"7884_CR238","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1111\/j.1528-1167.2008.01870.x","volume":"50","author":"EG Neal","year":"2009","unstructured":"Neal EG, Chaffe H, Schwartz RH, Lawson MS, Edwards N, Fitzsimmons G, et al. A Randomized Trial of classical and Medium-chain triglyceride Ketogenic diets in the Treatment of Childhood Epilepsy. Epilepsia. 2009;50(5):1109\u201317. Epub 20081119. doi: https:\/\/doi.org\/10.1111\/j.1528-1167.2008.01870.x.","journal-title":"Epilepsia"},{"issue":"6","key":"7884_CR239","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1542\/peds.102.6.1358","volume":"102","author":"JM Freeman","year":"1998","unstructured":"Freeman JM, Vining EP, Pillas DJ, Pyzik PL, Casey JC, Kelly LM. The efficacy of the Ketogenic Diet-1998: a prospective evaluation of intervention in 150 Children. Pediatrics. 1998;102(6):1358\u201363. https:\/\/doi.org\/10.1542\/peds.102.6.1358.","journal-title":"Pediatrics"},{"key":"7884_CR240","doi-asserted-by":"publisher","unstructured":"Martin-McGill KJ, Bresnahan R, Levy RG, Cooper PN. Ketogenic diets for Drug-Resistant Epilepsy. Cochrane Database Syst Rev. 2020;6(6): CD001903. Epub 20200624. doi: https:\/\/doi.org\/10.1002\/14651858.CD001903.pub5.","DOI":"10.1002\/14651858.CD001903.pub5"},{"issue":"1","key":"7884_CR241","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41421-023-00636-x","volume":"10","author":"YN Qiao","year":"2024","unstructured":"Qiao YN, Li L, Hu SH, Yang YX, Ma ZZ, Huang L, et al. Ketogenic Diet-produced Beta-Hydroxybutyric acid accumulates Brain Gaba and increases Gaba\/Glutamate ratio to inhibit Epilepsy. Cell Discov. 2024;10(1):17. Epub 20240213. doi: https:\/\/doi.org\/10.1038\/s41421-023-00636-x.","journal-title":"Cell Discov"},{"key":"7884_CR242","first-page":"63","volume":"5","author":"Y Kawada","year":"1989","unstructured":"Kawada Y. Sultamicillin in the Treatment of urinary tract Infections. APMIS Suppl. 1989;5:63\u201367.","journal-title":"APMIS Suppl"},{"issue":"1","key":"7884_CR243","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.1471-4159.2012.07670.x","volume":"121","author":"MA McNally","year":"2012","unstructured":"McNally MA, Hartman AL. Ketone bodies in Epilepsy. J Neurochem. 2012;121(1):28\u201335. Epub 20120207. doi: https:\/\/doi.org\/10.1111\/j.1471-4159.2012.07670.x.","journal-title":"J Neurochem"},{"issue":"1","key":"7884_CR244","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1528-1167.2007.00915.x","volume":"48","author":"KJ Bough","year":"2007","unstructured":"Bough KJ, Rho JM. Anticonvulsant mechanisms of the Ketogenic Diet. Epilepsia. 2007;48(1):43\u201358. https:\/\/doi.org\/10.1111\/j.1528-1167.2007.00915.x.","journal-title":"Epilepsia"},{"key":"7884_CR245","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.brainresbull.2022.12.011","volume":"193","author":"Z Wang","year":"2023","unstructured":"Wang Z, Li T, Du M, Zhang L, Xu L, Song H, et al. Beta-Hydroxybutyrate Improves cognitive impairment Caused by chronic cerebral hypoperfusion via Amelioration of Neuroinflammation and blood-Brain barrier damage. Brain Res Bull. 2023;193:117\u201330. Epub 20221226. doi: https:\/\/doi.org\/10.1016\/j.brainresbull.2022.12.011.","journal-title":"Brain Res Bull"},{"key":"7884_CR246","doi-asserted-by":"publisher","first-page":"216940","DOI":"10.1016\/j.canlet.2024.216940","volume":"593","author":"C Huang","year":"2024","unstructured":"Huang C, Tan H, Wang J, Huang L, Liu H, Shi Y, et al. Beta-Hydroxybutyrate restrains Colitis-associated Tumorigenesis by Inhibiting hif-1alpha-mediated angiogenesis. Cancer Lett. 2024;593:216940. Epub 20240508. doi: https:\/\/doi.org\/10.1016\/j.canlet.2024.216940.","journal-title":"Cancer Lett"},{"issue":"1","key":"7884_CR247","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12935-024-03277-6","volume":"24","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Li Y. Beta-Hydroxybutyrate inhibits malignant phenotypes of prostate Cancer cells through Beta-Hydroxybutyrylation of indoleacetamide-N-Methyltransferase. Cancer Cell Int. 2024;24(1):121. Epub 20240330. doi: https:\/\/doi.org\/10.1186\/s12935-024-03277-6.","journal-title":"Cancer Cell Int"},{"issue":"2","key":"7884_CR248","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.molcel.2016.03.036","volume":"62","author":"Z Xie","year":"2016","unstructured":"Xie Z, Zhang D, Chung D, Tang Z, Huang H, Dai L, et al. Metabolic regulation of gene expression by Histone Lysine Beta-Hydroxybutyrylation. Mol Cell. 2016;62(2):194\u2013206. https:\/\/doi.org\/10.1016\/j.molcel.2016.03.036.","journal-title":"Mol Cell"},{"key":"7884_CR249","doi-asserted-by":"publisher","first-page":"981285","DOI":"10.3389\/fimmu.2022.981285","volume":"13","author":"T Zhou","year":"2022","unstructured":"Zhou T, Cheng X, He Y, Xie Y, Xu F, Xu Y, et al. Function and mechanism of Histone Beta-Hydroxybutyrylation in Health and Disease. Front Immunol. 2022;13:981285. Epub 20220912. doi: https:\/\/doi.org\/10.3389\/fimmu.2022.981285.","journal-title":"Front Immunol"},{"key":"7884_CR250","doi-asserted-by":"publisher","first-page":"103433","DOI":"10.1016\/j.jri.2021.103433","volume":"148","author":"Y Hirata","year":"2021","unstructured":"Hirata Y, Shimazaki S, Suzuki S, Henmi Y, Komiyama H, Kuwayama T, et al. Beta-Hydroxybutyrate Suppresses Nlrp3 Inflammasome-mediated placental inflammation and lipopolysaccharide-Induced fetal absorption. J Reprod Immunol. 2021;148:103433. Epub 20211005. doi: https:\/\/doi.org\/10.1016\/j.jri.2021.103433.","journal-title":"J Reprod Immunol"},{"issue":"1","key":"7884_CR251","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s42255-019-0160-6","volume":"2","author":"EL Goldberg","year":"2020","unstructured":"Goldberg EL, Shchukina I, Asher JL, Sidorov S, Artyomov MN, Dixit VD. Ketogenesis Activates metabolically Protective gammadelta T cells in visceral Adipose tissue. Nat Metab. 2020;2(1):50\u201361. Epub 20200120. doi: https:\/\/doi.org\/10.1038\/s42255-019-0160-6.","journal-title":"Nat Metab"},{"issue":"6","key":"7884_CR252","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.cmet.2019.10.006","volume":"30","author":"CD Camell","year":"2019","unstructured":"Camell CD, Gunther P, Lee A, Goldberg EL, Spadaro O, Youm YH, et al. Aging Induces an Nlrp3 inflammasome-dependent Expansion of Adipose B cells that impairs metabolic homeostasis. Cell Metab. 2019;30(6):1024\u201339 e6. Epub 20191114. doi: https:\/\/doi.org\/10.1016\/j.cmet.2019.10.006.","journal-title":"Cell Metab"},{"issue":"1","key":"7884_CR253","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41392-021-00831-w","volume":"7","author":"H Zhu","year":"2022","unstructured":"Zhu H, Bi D, Zhang Y, Kong C, Du J, Wu X, et al. Ketogenic Diet for Human diseases: the underlying mechanisms and potential for clinical Implementations. Signal Transduct Target Ther. 2022;7(1):11. Epub 20220117. doi: https:\/\/doi.org\/10.1038\/s41392-021-00831-w.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"7884_CR254","doi-asserted-by":"publisher","first-page":"7115","DOI":"10.1038\/s41467-021-27426-x","volume":"12","author":"C Adam","year":"2021","unstructured":"Adam C, Paolini L, Gueguen N, Mabilleau G, Preisser L, Blanchard S, et al. Acetoacetate Protects macrophages from lactic acidosis-Induced mitochondrial dysfunction by metabolic reprograming. Nat Commun. 2021;12(1):7115. Epub 20211208. doi: https:\/\/doi.org\/10.1038\/s41467-021-27426-x.","journal-title":"Nat Commun"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-07884-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07884-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07884-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T23:36:06Z","timestamp":1776728166000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-07884-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":254,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7884"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-07884-x","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"assertion":[{"value":"10 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declaration and consent to participate"}},{"value":"All authors agree to publish this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"558"}}